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INTRODUCTION 
 
 The Siddha system, a branch of Indian systems of medicine, is holistic in its 
approach. Siddhar is a Tamil word that is derived from its root word ‘chitti’ which means 
perfection in life or heavenly bliss. The word “SIDDHA’ means ‘Ever sure’, ‘True’, 
‘Ever ready’ and ‘Everlasting’. Siddhar is one who attains “Kaya Siddhi” by protecting 
one’s constitution against diseases. The aim is to certify the body as the container of the 
soul for the attainment of happiness. 
 According to Siddha Medical Science, the Universe originally consisted of atoms 
which contributed to the five basic elements viz., Earth, Water, Fire, Air and Ether which 
synchronize with five senses of the human body, and they were the fundamentals of all 
the corporal things in the world. A close relationship is found existing between the 
external world and the internal system of human being. This is mentioned in siddha 
literature as, 
“mz;lj;jpy; cs;sNj gpz;lk; 
 gpz;lj;jpy; cs;sNj mz;lk; 
 mz;lKk; gpz;lKk; xd;Nw 
 mwpe;Jjhd; ghHf;Fk; NghNj.” 
    - rl;lKdp Qhdk; 
 This system believes that all objects in the Universe including human body are 
composed of five basic elements namely, earth, water, fire, air and sky. The food, which 
the human body takes and the drugs it uses are all, made of these five elements. The 
proportion of the elements present in the drugs varies and their preponderance is 
responsible for certain actions and therapeutic results. 
This system also considers the human body as a conglomeration of three 
humours, seven basic thathus and the waste products of the body such as faces, urine and 
sweat. The food is considered to be basic building material of human body which gets 
processed in two humours, body thathus and waste products. The equilibrium of humours 
is considered as health and its disturbance or imbalance leads to disease (or) sickness. 
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  “kWg;gJ cly;Neha; kUe;njd yhFk; 
       kWg;gJ csNeha; kUe;njd rhYk;    
     kWg;gJ ,dpNeha; thuhjpUf ;f 
    kWg;gJ rhit kUe;njdyhNk” 
       - jpUke;jpuk; 
 Siddhar Thirumoolar defines concept of siddha system of medicine is to treat the 
man as a whole and not merely the disease alone. He also denotes definition for drug, one 
that cures the physical, psychological ailments and preventing the ailments is medicine. 
Finally he denotes one that increase the longevity is medicine. 
 Siddha system of medicine has its own doctrine theory of fundamental principles 
based on hypothetical logic of natural law. This consist of  
 Anda pinda thathuvam. 
 Panja pootha thathuvam. 
 Tridhosa thathuvam. 
 Udhal thathuvam. 
 WHO defines health is a state of physical, mental, social, and spiritual well – 
being. The siddha system of medicine is an ancient one with spiritual qualities. 
PEDIATRICS IN SIDDHA SYSTEM: 
 In siddha system, the pediatric medicine is known as Balavagadam or 
Kuzhanthai Maruthuvam. But only a very little amount of literature is available for us. 
          Regarding the etiology of disease, they have told that 
Rf;fpyj;jpy; RNuhzpjq; fyf;Fkd;W 
             G+e;jpLk; tpahjp %d;W 
   - rpj;j kUj;Jthq;f RUf;fk;.                                                  
            Which means a child’s health is decided even at the time of conception. They 
have also told that the physical and mental condition and diet of the mother even during 
pregnancy and lactation, directly affects the child health and this be a causative factor of 
a disease or weakness of the child. 
 Siddhars had a vast classification of diseases – not ignoring even a minute 
symptom of the child. They had known that diseases attack the child from his fetal life 
and classified under ‘Karuvil thondrum noigal’. It seems from the literature that they 
have a variety of solutions for each and every problem, the child faces in day to day life. 
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Siddha system deals with Ante-natal care in well advanced manner with drugs for 
every month of pregnant women. Her diet, psychological conditions, environmental 
activities which are good for fetus are described well. 
 To see, the treatment aspect of pediatric medicines is unique. Considering the 
physical condition of child- oils, pills, decoction, chooranam, legium are the main forms 
of drugs used.  Parpams and chenthurams are rarely prescribed. 
Kuzhandhai Maruthuvam is a specialized branch in siddha medicine which deals 
with the treatment of the disease of children up to 12 years. Accordingly the lifetime of 
the child is divided in to various stages of paruvam. They are,  
 1-6 month  = Kaapu Paruvam 
 7-12 month  = Senkerai Paruvam 
 1-11/2 year  = Thalaattu Paruvam 
 11/2 –2 year  = Sappaani Paruvam  
 2-21/2 year  = Mutha Paruvam 
 21/2-3 year  = Varugai Paruvam 
 3-31/2 year  = Ampuli Paruvam 
 
   Male child    Female child  
 
31/2-4 year = Sitril Paruvam    Ammanai Paruvam 
4-41/2 year = Siruparai Paruvam    Neeraduthal Paruvam 
41/2-5year = Siruther Paruvam   Uonjal Paruvam 
 
Male      Female 
1-7 year  = Pillai Paruvam 1-7 year = Pethai 
Paruvam 
5-11 year  = Siru Paruvam  8-11 year = Pethumbai 
Paruvam 
12-19 year   = Valiba Paruvam 12-13 year = Mangai 
Paruvam 
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The diagnosis of Pediatric diseases is very difficult, even though the siddhars are 
pioneers in the diagnosis and treatment of pediatric diseases. 
my;ynyy;yhk; ePq;fp 
 mwpit mwpthywpe;J 
 ty;y rpj;jndd;Nw kfpo;Tw;Nwd; 
 khq;FapNy 
     - ghythflk; 
 “NgW ,sik gpzp %g;G rhf;fhL 
 ,it ahTk; fUtpy; mikT” 
- rpj;j kUj;Jt Neha;ehly;  Neha; Kjy; ehly; jpul;L 
 Therefore, Peadiatrics is the faculty of medicine which stands first in helping an 
individual to attain the eternal bliss by imparting physical well being even from the very 
budding stage. 
 
 Infectious disease and nutritional deficiencies are the twin problems among the 
health problem of children affecting their growth and development particularly in the 
developing countries like ours. Of the pediatrics diseases kabasuram is one of the 
commonest problems. Most of the clinical features of kabasuram described in Siddha 
literature are more or less similar to that of “Acute Bronchitis”. The modern comparison 
is made with Acute Bronchitis.  
 
 Sura kudari Mathirai and Kaba sura kudineer were chosen for this study, with 
reference from Kosaye Anuboga vaithya bhrama ragasiyam (part II). The medicines have 
been told to be effective and safe for pediatric usage. The author humbly contributes this 
work to the glory of siddha medicine.  
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AIM AND OBJECTIVES 
Kabasuram is one of the most common diseases in children and also it is most 
common infectious disease. 
 The principal aim of the present study of Kaba suram with clinical study 
is to collect and review the views and ideas of the ancient Siddhars about 
this disease.  
 To ensue a new approach in diagnosis for the disease. 
 To know whether the drug has better remedy or not. 
OBJECTIVES 
1. To identify the “Kabasuram” and its actual characters of the disease as per the 
siddha view. 
 
2. To explore definition, etiology, clinical features, diagnosis, investigations, treatment 
of kabasuram laid down from the siddha literature.  
 
3. To make the correlative study of the siddha & modern aspects of this disease. 
 
4. To evaluate clinical trial of the action of Sura kudari Mathirai and Kaba sura 
kudineer for Kabasuram. 
 
5. To evaluate the Bio-Chemical & Pharmacological analysis of the drug.  
 
6. To evaluate the efficacy of the trial medicine on Antimicrobial activity by invitro 
studies.      
 
7. To re establish the treatment for kabasuram with the Sura kudari Mathirai and 
Kaba sura kudineer. 
 
8. Finally, to create awareness among the public about siddha treatment for 
kabasuram.  
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                 PROTOCOL 
 
AN OPEN CLINICAL TRIAL OF SIDDHA DRUGS SURAKUDARI 
MATHIRAI AND KABASURA KUDINEER IN THE TREATMENT OF 
KABASURAM (ACUTE BRONCHITIS) 
     BY 
DR.G.POOVIZHI SELVI, PG STUDENT, DEPT. OF KUZHANDHAI 
MARUTHUVAM, NIS, CHENNAI 
1. BACKGROUND 
 
Kabasuram is one of the most important causes for lower respiratory tract 
infection. It is defined as one or more bronchi inflammation. It is common among 
children.  
In Koshaye Anuboga Vaithya Bhrama Ragasiyam (PartII) there is a preparation 
for Kabasuram, which is not in common practice. It is said to be highly efficacious.I 
would like to estimate the efficacy of this drug in an open clinical trial. 
According to  Pillaipini Maruthuvam,  
“nrhd;dhH rpNyw;g Ruk Jjhd; 
   Njhd;Wk; FspUk; gpd;Rukha; 
 kd;dh hpUK fhr;rYkha; 
  kyKk; gpbj;J tapW}Jk; 
 Fd;dhH tpl;L tpl;NlNd 
  Fsphe;j fhy;if mijj;J tUk; 
 ,d;dh hpe;jf; Fzk; fz;lhy; 
  ,JNghk; ehSk; gjp NdNo” 
     ifnaOj;J gpujp. 98 - 163 
 FspH, Ruk; Vw;gLk;, ,Uky; tUk;, kyKk; fl;bf; nfhz;L tapW}jpf; 
nfhs;Sk;.  fhy;, if mijj;Jf; fhzg;gLk; gjpNdO ehl;fspy; ,r;Ruk; 
Ngha;tpLk;. 
According to T. V. Sambasivam Pillai Tamil – English Dictionary, Kabasuram is 
phlegmatic fever.  It is associated with the following symptoms; Discharge of water from 
the eyes, formation of phlegm in the chest, hard breathing, tremor, burning sensation in 
the extremities, headache, fatigue, pain in the joints, perspiration etc. 
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fz;fspy; ePHtbjy;, fz;lj;jpy; Nfhio fl;ly; , ngU%r;R, eLf;fy; , if, 
fhy; vhpte;jk;, jiyNeha;, ,iug;G, %l;Lfspy; typ, tpaHj;jy; Mfpa 
FwpFzq;fisf; fhl;Lk;. 
2. AIM 
 
(a) Primary aim :  To find out the efficacy of Surakudari mathirai and                                           
KabasuraKudineer for the treatment of Kabasuram. 
(b) Secondary aim: To find out the side effects of the drugs, if any. 
3.  POPULATION AND SAMPLE 
   
The population consists of all patients with Kabasuram (chills, fever, cough, 
constipation with distended abdomen, edema in extremities) patients satisfying the 
inclusion and exclusion criteria mentioned below.   The sample consists of Kabasuram 
patients attending the OPD of Ayothidoss Pandithar Hospital of the National Institute of 
Siddha, Tambaram sanatorium, Chennai-47. 
4.  SAMPLE SIZE  
The trial size will be 50 patients.                                        
5.  INCLUSION CRITERIA 
 
1.  Aged 3 year to 12 year. 
2.  Willing to attend the OPD on 3rd and 6th day of treatment. 
3. Willing to give blood specimen for the investigation when required. 
6.  EXCLUSION CRITERIA 
 
Patients of convulsions, jaundice, distended abdomen, congenital heart disease or 
any other serious illness are not eligible for this trial. 
7.   WITHDRAWAL CRITERIA  
 
1. Adverse drug reactions. 
2. Occurrence of any other serious illness. 
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8.    TRIAL DRUG, DOSAGE, DURATION 
                      
Drug Regimen: 
 The mode of administration of the trial drugs are given below. 
1. Surakudari mathirai: 1tab = 250 mg 
Age Dose 
3– 5 Years ½  tab b. d. 
6 – 12 years 1 tabs b. d.  
  
 2.   Kabasura Kudineer 
Age Dose 
3– 5 Years 15 ml b.d 
6 – 12 years 30 ml b.d 
    Trial treatment period – 5 days 
9. TESTS AND ASSESSMENTS 
(a) Siddha  Assessments 
Suram, Erumal, Moochuvida siramam, Udal sorvu, Poriyal arithal, Pulanal arithal,  
Vinathal, Envagai thervuagal, Paruvakaalam, Thinaikal, Udal Kattukal, Uyir 
Thathukkal. 
(b) Clinical Assessments 
Fever, Cough with expectoration, Night cough, Arthralgia, Breathlessness, 
Wheezing 
(c)   Siddha Investigation 
  
The diagnosis was made with the help of following Siddha methods. 
Neerkuri, Neikuri, Malam. 
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(d) Investigations  
   
Blood Test – TC, DC, ESR, Hb, Widal, Smear for MF,  Smear for MP, Urine --  
Albumin, Sugar, Deposits, Bile Salt, Bile pigment ,  Urobilinogen, Motion – Ova, 
Cyst , Occult blood and Sputum – AFB. 
10. CONDUCT 
 
Kabasuram patients satisfying the inclusion and exclusion criteria will be 
admitted to the trial. Informed consent will be obtained from the parents. 
Blood sample will be taken before treatment and at the end of the treatment. 
Patients admitted to the trial will be issued the trial drugs initially for 2 days and for 3 
days when they come for the next clinic visit. They will be instructed to bring back 
unconsumed trial drugs and return them during their next visit. 
11. FORM 
 
 Form I:    Selection proforma - Used before admission to the trial. 
Form II :   Assessment proforma - Used at the end of the treatment. 
12. ANALYSIS 
Changes in subjective parameters will be analyzed using Paired X2- test and                                                                                                                                                                                      
changes in objective parameters will be analyzed using Paired t-test. 
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REVIEW OF LITERATURES 
SIDDHA ASPECT 
Ruk; 
 
,ay; 
Flypy; rPjk; mjpfkhfp clypd; ,aw;ifr; R+L jd;dsTf;F kpQ;rp vOe;J 
fz;vhpjy;, tha;Fkl;ly;, cly; Nehjy;, the;jpahjy; Mfpa gy 
FwpFzq;fis Njhw;Wtpf;Fk;.  
,jidj; Njud;, 
   “Fly;jd;dpy; rPjkyhJ RuKk; tuhJ” 
- Njud; 
Ruk; vd;Dk; nrhy; RH + mk; vdg; gphpf;fg;gl;L RH = RLjy; mk; = 
cilaJ. RLjiyAila Neha; vd;W nghUs; gag;gjhFk; vd xUtifahd 
njspjyhFk;. 
 epyq;fspy; jdf;Fr; rpwg;ghf ntg;gj;ijg; ngw;W ,Uf;Fk; ghiyepyk; Ruk; 
vdg; ngaH ngw;wJ Nghd;W, ek; clypw;Nwhd;Wk; Neha;fspy; ntg;igr; 
rpwg;ghfg; ngw;w ,e;NehAk; Ruk; vdg; ngaH ngw;wjhFk; ,jid, 
 “Ruepyk; Nghy RLNeha; Runkd; 
 Wiug;gH nrwpfdj; Jz;lh kdyk; 
 euk;gpd; topNa jz;zPH clk;gpd; 
 ngUFk; ntg;gk; gpionra; NehNa” 
- rpj;j kUj;Jtk; 
vd;gjhy; mwpayhk; 
NtWngaH: 
 ntk;ik, ntg;GNeha;, fhe;jy;, fhq;if, fha;r;ry;, R+L, mdy;, 
gpwg;gpYk; ,wg;gpYk; njhlUk;Neha;, gk;ky;Neha; vdg;gy  ngaHfSz;L. 
,jid, 
 “ntk;ik ntg;G ntWf;Fq;fha;r;ry; 
 Jk;khf; fhq;if R+L joydy; 
 Rk;ikg; gpwg;gpy; ,wg;gpy; njhlHNeha ;  
 gk;ky;Neha; fhe;jy; gy ngaH RuNk” 
- rpj;j kUj;Jtk; 
vd;gjhy; mwpayhk;.
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Neha; tUk; top 
 ”gz;Ls kyj;jpdhYk; 
  gofpa rPjj; jhY; 
 cz;bapd; nghy;yhq; fhYk; 
  xz;nlhb Nghfj; jhYk; 
 fz;L apyhik ahYk; 
  fLfpa Nthl;lj; jhYk; 
 kpz;ba RitapdhYk; 
  ntg;G te;jZFq; fhNz” 
 ”<q;nfO Nfhgj; jhYk; 
  ,sntapw; fha;j yhYk; 
 jhq;nfhzhr; Rik fshYk; 
  rUfpiy A+w yhYk; 
 Xq;fpa grpap dhYk; 
  cz;bNk Yz;b ahYk; 
 Njq;fpa kyf;fl; lhYk; 
  jPantg; gZF kd;Nw. ” 
 ”fLntapy; kiof shYk; 
  fjwpa Fuyp dhYk; 
 tplkJ gLj yhYk; 
  ntUtpa Ntfj; jhYk; 
 Kbkpir naz;nza; Nja;j;J 
  %o;fpa Nghfj; jhYk; 
 jbab gLif ahYk; 
  rhHe;jpLk; ntJg;Gj; jhNd 
 “gotpid ahY nkj;j 
  grpj;jpUe; Jz;if ahYk; 
 FspHikePHf; Fzj;jp dhYk; 
  Ftya Ngjj; jhYk; 
 ,sfpa Tz;b ahYk; 
  ,jaj;jp ndz;zj; jhYk; 
 cskJ cisj yhYk; 
 cWRu nka;Je; jhNd.” 
 
mjhtJ, 
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 vU (kyk;), jilg;gly;, ehl;gl;l Iak,; cz;bahy; Vw;gLk; nfLjpfs,; 
gytifg;gl;l eQ;Rfs;, Japypd;ik, fLikahd Xl;lk;, mjp RitAs;s 
nghUis cz;zy;, mjpNfhgq; nfhs;sy;, ,sntapy;, fLntapy;fspy; 
elj;jy;, jhq;nfhzhg; grpiag; nghWj;jy;, cz;bNky; cz;b cz;zy;, 
jhq;fKbahr;Rik, Rkj;jy;, fjwpf;$ty;, clypnyOk; gjpdhd;F Ntfq;fis 
mlf;Fjy,; jbabia Nkw;nfhs;sy;, gLf;if NtWgLjy,; jhd; nra;j 
gotpidfs; R+o;jy;, kpf;f grpapy; tapW epiwag; Grpj;jy,; mjp FspHe;j ePiug; 
gUFjy;, nfl;l vz;zq; nfhsy;; Kjypa nray;fs; RuNeha; Njhd;Wtjw;fhd 
topfnsd Nkw; $wpa ghf;fshy; mwpayhk;. 
 
Neha;vz;  
 ghythflj;jpy; Ruvz; 20 vdf; Fwpg;gplg;gl;Ls;sJ 
 
mitahtd 
1.  thjRuk;    2. gpj;jRuk;    3. fgRuk; 4. kPshjIaRuk; 5. khe;jRuk; 
6.  mjprhuRuk;  7. MkRuk;    8. jPuhj MkRuk; 9. rPjRuk;  10. FspHRuk;  
11. tplRuk;    12. khww;Ruk;  13. fzr;Ruk;  14. cl;fha;r;ry; Ruk;  
15. ,uj;jRuk; 16. khq;fprRuk; 17. mj;jpRuk; 18. jhgr;Ruk;  
19. clk;GNeha;f;fha;r;ry; 20. md;gdhjpRuk;  
kUj;Jtj;jpy; jd;topr;Ruk; 52 gpwtopr;Ruk; 12 vd nkhj;jk; 64 vd 
Fwpg;gplg;gl;Ls;sJ.  mitahtd. 
jd;topr;Ruk; 
1. thjRuk;  2. gpj;jRuk;  3. fgRuk;  4. thjgpj;jRuk;  5. thjfgRuk;   
6. gpj;j thjRuk;  7. gpj;jfgRuk;  8. fgthjRuk;  9. fggpj;jRuk;  
10. fyg;Gr;Ruk; 11. ke;jRuk;  12. espHRuk;  13. ntQ;Ruk;   
14. Nkdpr;Ruk;   15. cs;Ruk;    16.  ntspRuk; 17. tpl;LtUk; Ruk;    
18. tplhr;Ruk;     19. rhw;wRuk;  20.  nrq;fiwr;Ruk;    21. Cd;Ruk;   
22. nfhOg;G Ruk;   23. vd;Gr;Ruk; 24. %isr;Ruk;  25. tpe;JRuk;   
26. Jd;gr;Ruk;  27.KiwRuk;  28. kaf;fRuk; 29. gpjw;wy;Ruk;   
30. GOr;Ruk;. 31.kQ;rl;Ruk;  32. fhiyr;Ruk;  33. gfw;Ruk;   
34. khiyr;Ruk;  35.  ,uhr;Ruk;  36.  mjpfhiyr;Ruk;   
37. jPtul;rpr;Ruk; 38.  mdy;Ruk;  39.  Vg;gRuk;  40.  the;jpr;Ruk;  
41.nfhl;lhtpr;Ruk;  42.  tpltpf;fy;Ruk;  43.  tpaHitr;Ruk;  
44.J}q;fhr;Ruk;  45. ,Uky;Ruk;  46.  goQ;Ruk;  47.  fl;br;Ruk;   
48.  rPo;r;Ruk;  49. gy;nfhg;Gsr;Ruk;  50.  eLf;fy;Ruk;  51.  tPf;fr;Ruk;   
52.  fopr;rw;Ruk;  
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Kw;FwpFzq;fs; 
 cz;Zk; vg;nghUspYk; tpUg;gkpy;yhjpUj;jy;, clk;G 
RikahapUj;jy; , czTnrhpahik, nfhl;lhtp, kaf;fk; , 
ehr;Ritawpahik, cly; eLq;fy,; FspHjy; , ,utpy; J}f;fkpd;ik, 
njhil nfz;ilr;rij Nehjy; , cly;Kw;Wk; Fj;jy; , Filr;ry; , 
clypy; tpaHitNjhd;wy; , fz;fspy; ePH Kl;b Kl;b ntspg;gly; , 
ehtwz;LNghjy; Mfpa ,f;Fwpfspy; gyNtDk; rpyNtDk; Ruk; 
cz;lhtjw;F Kd;dHf; fhzg;gLk;. 
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fgRuk;;; 
According to Balavagadam 
 “khq;fpre; jd;dpy; thj kJgpj;jk; jhDe; Njhypy; 
 J}q;fpL nkYk;gp iyaQ; Rfkwj; Njhd;wpg; gpd;dH 
 rhq;fpa khf epd;W rhPuj;jpy; NehAk; gz;Zk; 
 Mq;fpijr; nrhy;y nthz;zh jePjkhk; Nuhfe; jhNd” 
       - ghythflk; 
Foe;ijfl;F cz;lhFk; Ruk; Iakhfpy; vYk;igr; rhHe;J cliy 
ntJg;gp tUj;Jk;. 
According to Pillaipini Maruthuvam 
 “nrhd;dhH rpNyw;g Ruk Jjhd; 
   Njhd;Wk; FspUk; gpd;Rukha; 
 kd;dh hpUK fhr;rYkha; 
  kyKk; gpbj;J tapW}Jk; 
 Fd;dhH tpl;L tpl;NlNd 
  Fsphe;j fhy;if mijj;J tUk; 
 ,d;dh hpe;jf; Fzk; fz;lhy; 
  ,JNghk; ehSk; gjp NdNo” 
     if.gp. 98 - 163 
 FspH, Ruk; Vw;gLk; ,Uky; tUk;, kyKk; fl;bf; nfhz;L tapW}jpf; 
nfhs;Sk;.  fhy;, if mijj;Jf; fhzg;gLk; gjpNdO ehl;fspy; ,r;Ruk; 
Ngha;tpLk;. 
According to Yugi Vaithiya Sinthamani 
 gUfnt Rue;jhDk; gyfh Yz;lhk; 
  ghukh Alk;ngq;Fk; typA z;lhFk; 
 mUfNt abf;fbf;F tpaHit ahFk; 
  md;de;jhd; nfhz;LlNd the;jp Az;lhk;. 
 cUfNt tapnwy;yh Kisr;ryhFk; 
  cg;gprK Nky;%r;R kpUk Yz;lhk; 
 fUfNt ehtuz;L ePHjh fpf;Fk; 
  fdkhd RurpNyl;gq; fhzr;nrhy;Ny 
- ghly; vz;. 407 
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Ruk;, clk;Gtyp, the;jp, tpaHit, tapW, cisr;ry; , cg;gprk; , 
Nky;%r;R, ,Uky,; ehtwsy; Mfpa FwpFzq;fs; fhzg;gLk;. 
 
According to T. V. Sambasivam Pillai Tamil – 
English Dictionary. 
 It is phlegmatic fever.  It is associated with the 
following symptoms, discharge of water from the eyes, 
formation of phlegm in the chest, hard breathing, 
tremour, burning sensation in the extremities, 
headache, fatigue, pain in the joints, perspiration etc. 
 fz;fspy; ePHtbjy;, fz;lj;jpy; Nfhio fl;ly; , ngU%r;R, 
eLf;fy; , if, fhy; vhpte;jk; , jiyNeha; , ,iug;G, %l;Lfspy; 
typ, tpaHj;jy; Mfpa FwpFzq;fisf; fhl;Lk;. 
According to Pararasa Sekaram 
 “nrd;dpkpff; fzj;jpbj;Jr; rPwpKf Kq;fdj;J 
 kpd;Dkdy; Nghw;RuK nkd;NkY NkKLfp 
 kd;Drpuj; J}ljpf typapbg;G NkahFk; 
 md;deil kpdNdap jwpitNrw; gdRuNk.” 
- ghly; vz; 366. 
jiyg;ghuk;, fghy ,b, rpdk; nfhs;Sjy;, Kfk; fdj;J neUg;GNghy; 
Ruk; fhAk; jiytyp mjpfkhff; fhZk;. 
According to Pothu Maruthuvam 
 “KfkJ ntSf;Fk; ehf;F Kz;Zz Thprpapy;iyj; 
 jfKl dpUky; tpf;fy; je;JkhH njhz;il NehFk; 
 kfTly; jpdT tha;ePH mbj;njhil NrhHt jhFk;  
 nrfKjy; Rue;jhd; fhzpy; Nrj;Jk nkd;d yhNk” 
 Iar;Ruj;jpy; Kfk; ntSf;Fk;, cz;Zk; czit ehr;Rit mwpahJ.  
,Uky;, tpf;fy; cz;lhFk;, khHGk; njhz;ilAk; NehFk;..  cly; jpdT 
tha;ePH Cwy; Kjypad Vw;gLk;. 
According to Suravagadam 
 “miwAQ; Nrj;k RukJju 
  dilNt Alk;G nfhe;jow;Wk; 
 epiwa ,Uk;g ypisg;Gz;lhk; 
  neQ;R kpsfp kde;JtSe; 
 jpiu Nrud;dq;  nfhs;shJ 
  jpUl;b apUl;bj; jpUk;gpd;id 
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 AiwA Klypy; kyrye;jh 
  Diuf;fpy; ntspWk; tpiuFoNy” 
  
 “tpiutha;j; Japy;t jhpjhFk; 
  tpopJQ; rhJ kpff;fhAk; 
 Giuth Alk;G FspHe;jpUf;F 
  gPis topA kpUfz;Zk; 
 jpiuNrH eQ;r kKjhf;FQ; 
  rptidj; Jjpah jtHrkaj; 
 JiuNghy; tapW Kld; fopA 
  Kly;ntg; ghfp AoiyAz;Nl” 
 IaRuj;jpy; cly; nehe;J mow;wy;, ,Uky;, ,isg;G, fisg;Gg; 
gpwg;gpj;jy;, neQ;R ,sFjy,; kde;Jtsy,; Cz; nfhs;shik, kyKk; ePUk; 
fopjy;, vg;nghUspYk; ntWg;giljy;, J}f;fkpd;ik, Ruk; fha;jy; gpd;G 
jzpjy;, ,U fz;fspYk; gPis rhuy;, tapW fopjy;, cly; ntg;gkhjy; 
Kjypa FwpFzq;fs; cz;lhFk;. 
Fw;wKjypa NtWghLfs; 
 “Nfsg;gh Ruk;gpwf;Fk; tifiaj; jhNd 
  nfbahd mWRitapd; Ngjj;jhYk; 
 jhsg;gh jfhj jk; elf;if ahYk; 
  jUthd thjgpj;j rpNyj;k nkd;Dk; 
%sg;gh Kj;Njhl nkhd;wha;f; $b 
  Kbthf tpuz;buz;lha;j; njhe;jpj; Njjhd; 
 R+sg;gh jdpj;jdpNa Mf;ukpj;Jr; 
  Rfkhd thkhrak; gw;We; jhNd” 
 “gw;wpaq;F kpUJnfl;b &g khfg; 
  gbe;jpUf;Fk; MkndDQ; rpNyj;k tiliaj; 
 jj;jpjq;fs; td;ikf;Fj; jftp sf;fpj; 
  jFe;jgb at;tilia Ag;gr; nra;J 
 rf;jpjUk; md;dj;ijr; nrhpar; nra;J 
  rJuhd rPuzj;jpd; euk;gpd; Jthuk; 
 Rj;jptUk; Nuhkj;jpd; Jthue; jd;idr; 
  Rfkhf kiwj;jgpd;G nrhy;yf; NfNs.” 
 “nrhy;YfpNwd; gf;Fthraj; jhdk; NrHj;Jr; 
  Rfkhf tsHe;JtUk; rluhf; fpdpia 
 nky;yNt tprpwpNa naOg;gp tpl;L 
  nkJthf mjDlNd jhDQ; NrHe;J 
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 ty;yNt rhPuj;jpy; gutpg; gpd;G 
  tykhf cly; KOJk; nfhjpg;igj; je;J 
 my;yYld; Njfj;ijf; nfhLik nra;Ak; 
  moyhd Rukjdpd; wd;ik jhNd.” 
mjhtJ, 
Nkw;$wpa mWRitAz;bapd; Ntw;WikfshYk;, jfhj elj;ijahYk;, 
tspKjyhd Kf;Fw;wj;jpDs; xd;W jdpj;NjDk; , ,uz;Lq; $bNaDk; , 
%d;Wq; $b xd;whf ,ize;NjDk; mitfspd; ,aw;if msit fle;J 
epw;Fkhjypd; Ntw;Wikaile;j Fw;wq;fs; ,iug;igiag; (Mkhraj;ijg;) gw;wp 
nky;ypajhfTk;, rw;Wf; fbdtbNthL milNghd;W, ,aw;ifaha; mfl;bd; 
cl;Gwk; gbe;Js;s ,t;itatilia, kpFe;njOe;j Fw;wq;fspd; td;ikf;Fj; 
jf;fthW, ,sf;fp cg;gr; nra;tpf;Fk; mfl;by; (,iug;igapy;) ,sfpg; ngUj;j 
me;j Ia milahdJ, clw;F td;ik jUk; czit nrhpg;gpf;fhjgb nra;Ak;.  
mt;thW rhptur; nrhpah czTf;Folk;igAk; mZfp, ehNlhWk; mf;Fok;igr; 
(,urj;ij) nrYj;Jfpd;w JisfisAk; milj;J kapHf; fhy;fspd; fz;izAk; 
kiwf;Fk;.  mjd;gpd; Flw;F (gf;Fthraj;Jf;F) nrd;W mq;F ,aw;ifaha; 
,aq;Fk; clw;wPiaAk; tprpwp NknyOg;gp cly;Kw;Wk; mt;tdiyg; gutr; 
nra;Ak;.  ,t;thW fjpe;njOe;j mdNy Ruk; vdg;gLk;. 
 
 “Ruk;gpwf;Fk; tifajidr; nrhy;Ntd; Kd;dhy; 
  nrhd;dtop aWRitAk; khw yhYk; 
 ngUe;jfh eltbf;if ahy;Kf; Fw;wk; 
  gphpahkw; $bAkq; fpuz;b uz;lha; 
 kUtpNa jdpj;jdpaha;r; R+o;e;J Kd;dH 
  khRglh jpUe;jth kj;ijg; gw;wp 
 XUTjyp yhkyjd; nkd;ik nfl;b 
  AUtr;rP jj;jpdil ajidr; NrHe;Nj. 
 jq;fSil td;ikjidf; fhl;b ajdpd; 
  jd;topnfl; Lg;Gk; top jd;idr; nra;J 
 Eq;FKz thjpfisr; rkpj;jy; nra;ah 
  NehalHe;J rkpeuk;gpd; topAkaphpd; 
 jq;Ftop jikkUj;Jg; gf;Fth raj;ijr; 
  rhHe;Jtd Ylw;wPia tprpwpj; J}z;b 
 mq;fjpw;wh Kq;$b Aly Kw;Wk; 
  moyhf;fp ay;yy;gy tpisf;Fe; jhNd.” 
      - mfj;jpaH Fzthflk; 
vd kw;nwhU ghlYk; cz;L 
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 Nkw;$wpa ,uz;L E}yhrphpaHfSk;, rpNyj;Jk mil vd;Dk; nrhy;iy, 
‘Mkk;’ vd;Dk; tlnkhop nrhy;Yf;F ,izahf;fp $wpaJ.  me;E}y; 
topj;jOTjiyf; Fwpf;Fk;.  jkpo; kUj;Jt topapy; Nehf;fpy; Njud; 
Nrfug;ghtpjidr; , 
 “. .  . . . . . . . . . . . . . . . Fly; jd;dpw; 
 rPjkyhJ RuKk; tuhJ jpwkhNk” 
     - Njud; 
vd;wjdhYk; 
 mrPuzkpd;wpr; RuKk; thuhJ .  . . . . . . . . . . . . . . ”  
vd;wjdhYk; , 
“vd;W JhpNah jdD 
  kpisatD kq;fH NfhDk; 
 vd;WklNk GhpAk; 
  vz;zKs rFdpAk; 
 ke;juh Nyhrid nad;Dk; 
  ke;j trPfuz Kz;lha;j; 
 je;jpu Gspg;G kPwpj; 
  jhdida ntg;g khdjpdhNy” 
     - NjuH kUj;Jt ghujk; 
vdj; NjuH kUj;Jtg; ghujj;jpy; $wpajhYk;. 
 czT nray; Kjypa NtWghl;lhy; Ruk; tUKd; ,iug;igapy; <uy; fl;b 
R+y; nfhz;L, cz;l czitr; rikf;fhJ, Gspj;J, nrhpahj Gspj;j czTr; 
rhW rikehsq;fs; topNa (Lymphatic vessels) kapHf;fhy; JisiaAk; 
milj;J, rpWFliyr; rhHe;J, clw;wPiag; ngUf;fpg; gutr; nra;j tspKjypa 
Fw;wq;fs; khWjypd; td;ikf;Fj; jf;fthW Ruj;ij ntspahf;Fnkd ciuj;jy; 
rpj;jH E}y; topahnkdf; nfhs;sf; fplf;Fk;. 
 ,r;Ru Nehapy;  clypy; czTg;igAk,; FlYk; ,aw;ifj; njhopypy; 
nfLtjhy;, cztpd; rhuk; nfLk;. 
 
ehbeil 
 “ghq;fhd thjj;jpw; Nrj;Jk ehbg; 
  ghprpj;jhy; jpkpHNkT Kisr;ryh Fk; 
 jPq;fhd ,UkYld; re;ep Njhlk; 
  NrHe;jtplk; ntbR+iy ,Uj; Nuhfk; 
 thq;fhj <iske; jhu fhrk; 
  typAlNd GwtPr;R cs;tPr;R tPf;fk; 
 xq;fhZQ; RuKlNd Rthr fhrk; 
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  cz;lhFk; ntFNeha;f;F KWjp jhNd.” 
    - Neha; ehly; Neha; Kjy; ehly; jpul;L 
mjhtJ, 
 thj Ia njhe;j ehbapy; clypy; jpkpH cz;lhjy;, cisr;ry;, ,Uky; 
, Ruk; , rd;dp, ntbR+iy, ,Uja Nuhfk; (jkufNeha;), <is, ke;jhufhrk; 
, cs;tPr;R, GwtPr;R, cly;tPf;fk; , Rthrfhrk; , cly; , eh, if, fhy; 
,itfs; jpkpHj;jy; , typNeha; , jiytyp, ntt;NtW NjhlFzq;fs; , nka; 
ntSj;jy; , czT nry;yhik, Ngr;Rj; jLkhwy; , tPf;fk; ehSf;F ehs; 
mjpfg;gly; Mfpa ,f;FwpFzq;fis tpistpf;Fnkd;gjhk; vdNt thj Ia 
njhe;j ehbapy; Ruk; ,Uky; Nghd;w FwpFzq;fs; Njhd;Wk; vd;gij mwpayhk;. 
RuNehapy; gpwf;Fk; JizNeha;fs; 
 “RukNj fdyjhFk; RukNj rPjkhFk; 
 RukNj Njhl khFk; RukNj NrhifahFk; 
 RukNj Nkf khFk; RukNj fgK khFk; 
 RukNj rhukhFk; RukNj jhfkhNk 
 RukNj twl;rpahFk; RukNj tpuj;j khFk; 
 RukNj rPOkhFk; RukNj k[;i[ ahFk; 
 RukNj fiza jhFk; RukNj ,Uk yhFk; 
 RukNj rakjhFk; RukNj nghUk yhNk 
 RukNj R+iyahFk; RukNj nrhwpa jhFk; 
 RukNj tpuz khFk; RukNj gpj;j khFk; 
 RukNj thj khFk; RukNj thA thFk; 
 RukNj <is ahFk; RukNj ,Og;G khFk;.” 
- mfj;jpaH RuE}y; 300. 
RuNehapy; rPjk;, Njhlk;, Nrhif, Nkfk;, fgk;, jhfk;, twl;rp, rPo,; 
fiz, ,Uky;, rak;, nghUky;, R+iy, nrhwp, tpuzk;, <is, ,Og;G 
Nghd;w Jiz Neha;fs; gpwf;Fk; vd;gij mwpayhk;. 
Ru NehapYz;lhk; Njhlf;Fwp Fzq;fs; 
 “jathd Rue;jdpNy tplK khfh 
  rhHe;jtple; jdpNy Njhle; jiof;f yhfh 
 gakhd Njhlkjpy; re;ep ahfh 
  ghq;fhd re;epapNy fgK khfh 
 ,ay;ghd fge;jdpNy tPf;f khfh 
  tpsq;fpaNjhH tha;tjpNy ,isg;G khfh 
 fakhd ,isg;gjpNy Rthrk; tpf;fy; 
  fye;jhYk; kuznkd;W fow;w yhNk.” 
- rjf ehb 
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 RuNehapy; tplKk; mj;Jld; Njhlk;, rd;dp, fgk;, tPf;fk,; tha;T, 
,isg;G, Rthrk,; tpf;fy; ,it xd;wd;gpd; xd;wha;j; Njhd;wpy; kuzk; 
epr;rakhk;. 
kw;Wk;, 
 “,ire;jgb Rue;jdpNy ,isg;G khfh 
  ,isg;ghd fge;jdpNy tplK khfh 
 cre;jtple; jdpy;kaf;fk; thA thfh 
  cz;lhd kaf;fkjpy; Rthr khfh 
 mire;jpyFk; Rthrkjpy; tpaHit ahfh 
  Mdfg tpaHitapNy FspHr;rp ahfh 
 tire;jpyFq; FspHr;rpapNy kaf;fk; tpf;fy; 
  te;jhYk; kuznkd;W toq;f yhNk.” 
     - Neha; ehly; Kjy; ehly; jpul;L 
mjhtJ,  
 RuNehapy; ,isg;G,  tplk;, kaf;fk;, tha;T, tpaHit, rPjsk;, 
tpf;fy; ,it njhlHghfj;  Njhd;WNkahdhy; Nehapdd; rhtJ epr;rankd 
mwpaTk;. 
 Nkw;fz;l ,uz;L ghlypYk; Njhd;wpa FwpFzq;fs; ,e;Nehapy; 
Njhd;Wkhdhy; NehahdJ jPuhJ.  Nehahsp rhthd;. 
 
mrhj;jpaf; FwpFzq;fs; 
 “IaRuj;jpd; Fzq;Nfsh afl nghUkpf; fz;ntSf;Fk; 
 ifAq;fhYQ; NrhHe;J tpOk; fz;f Ss;Ns jhd;tPOk; 
 njha;ay; RuKk; tplhjJTk; nrhy;Ye; Njhl khdhw;Nghy; 
 nka;A ehf;F Nktuz;L tpf;f nyLf;F kPshNj.” 
 
 “nka;apy; te;j itaRuk; tpl;L tpl;Nl jhd;ntJk;gpf; 
 ifAq; fhY NkntJk;gpf; fd;dq; fhA neQ;rpbf;Fk; 
 ca;a Koiy the;jpAz;lh Nkhb Nahbf; fl;Lk/ 
 ijak; gpiog;g jhpJz;lh ajpf khFe; Rue;jhNd.” 
      -  ghythflk; 
 
 tapWnghUKjy;, fz;fs; ntSj;jy;, ifAq; fhYk; NrhHjy;, fz;fs; 
FoptpOjy;, ,itfshy; Njhlkhdhw; Nghy; clYk; ehf;Fk; tuSjy;, 
tpf;fYz;lhjy; Mfpa FwpFzq;fs; ,e; Nehapy; Njhd;Wkhdhy; gpiog;gJ mhpJ. 
 if, fhy;, fd;dk; ,t;tplq;fs; ntJk;gpf; fha;jy;, khHGNehjy;, cly; 
typj;jy;, the;jp, clypy; ,q;Fkq;Fk; fdj;Jf; fl;bNghw; fhzhkw; kiwjy;, 
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Ruj;jpd; Ntfk; msT fle;J fhzy; Mfpa ,f;FwpFzq;fs; fhzg;gl;lhYk; 
,e;Neha; jPuhJ. 
NkYk;, 
 nta;aRue; jdpypUky; Jug;G tpf;fy; 
  nka;FspHj Yld;NtHit Auk;nt Jk;gy; 
 nra;aKfq; fuk;ghjk; ntSj;Jf; fhl;ly; 
  jpaf;fKwy; %r;rpioj;jy; gpujh gq;fs; 
 Iailj;Jf; FWFWj;j tjprh uq;f 
  sdnyOk;g yhdFz kitfs; fz;lhy; 
 IaRu khrj;akh nkd;Nw ape;j 
  thahd;ed; kiwajp ypak;gp dhNu 
- rpj;j kUj;Jtk; 
,Uky;, tpf;fy;, nka;Fspuy;, tpaHit, cly; ntJk;gy;, Kfk,; 
if, fhy; ,itfs; ntSj;jy;, jaf;fk,; ngU%r;R, khHgpy; Nfhio fl;b 
FWFWj;jy;; kpf;fNgjp ,itfisAila IaRukhdJ kUj;JtH iff;F 
trg;glhnjd;gjhk;. 
Piniyari Muraimai (Neha; fzpg;G)  
Piniyari muraimai is a method of diagnosing a disease. 
  “Pini” means    =   Disease 
  “Ari” means  = Identify 
  “Muraimiai” means   =   Method 
This is based upon three main principles and Envagai Thervugal. The three main 
principles are, 
1. Poriyal arithal (Inspection) 
2. Pulanal arithal ( Palpation) 
3. Vinathal ( Interrogation) 
 Physicians ‘Pori’ and ‘Pulan’ are used as tools for examing the ‘Pori Pulan’ of 
the patient. The above principles correspond to the methodology of  
1. Inspection   2. Palpation and 3. Interrogation in modern medicine, in arriving 
a clinical diagnosis of the disease. 
1. Poriyal arithal (Inspection) 
Pori is considered as the five senses of perception namely, 
     1. Nose  
                2. Tongue   
                3. Eye    
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                4. Skin  
                5. Ear. 
 2. Pulanal arithal ( Palpation) 
  Pulan are functions of five senses. They are, 
1. Smell 
2. Taste 
3. Vision 
4. Sensation of Touch 
5. Hearing. 
Vinathal ( Interrogation) 
Vinathal is asking the information regarding the history of the disease, its clinical 
feature etc., from the patient or his close relatives who are taking care of him. 
msitfs; : (Logics): 
Alavaigal are used in clinical diagnose of a disease. 
“msit fhz;ly; fUjy; ciu mghtk; nghUs; xg;ghnwd;gH 
msit NkYk; xopGz;ik iajpfj; Njhbay; ngd ehd; 
fsit fhz;gH mitapw;wpd; NkYk; miwtH mitnay;yhk; 
msit fhz;ly; fUjy; ciu vd;Dk; %d;wpylq;fpLNk” 
- rptrpj;jpahH msit vz;. 6 
 Alavai is divided into ten types, They are, 
1. Observation    –  fhz;ly; 
2. Inference    – fUjy; 
3. Authority, literature  – ciu 
4. Preception    – mghtk; 
5. Presumption   – mUj;jg;gj;jp 
6. Comparison   – cgkhdk; 
7. Inference by elimination  – ghhpNr\k; 
8. Probability    – rk;gtk; 
9. Tradition    – IjPfk; 
10. Natural Inference   – ,ay;G 
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The above mentioned “ten alavaigal” are included in three alavaigal. They are, 
1.  Kaandal ( Inspection by Siddha method) 
           Through ‘Kaandal’ the physician can directly see the patient, hear the patients all 
the complaints and at length concludes a diagnosis. 
2. Karuthal (Through Siddha Investigations) 
 Through Envagai thervu and Neerkuri as well as Neikuri, we can diagnose a 
disease by Karuthal. 
3. Urai ( Literature evidence of Siddha) 
 Comparative study of  the signs and symptoms of the patient with the reference 
books and come to a diagnosis. 
Ennvagai  thervuagal (Eight diagnostic tools) 
Siddhars have developed a unique method of diagnosing the disease by “ Enn 
vagai thervugal”. 
 
“ehb ];ghprk; eh epwk; nkhop tpop 
 kyk; %j;jpukpit kUj;Jt uhAjk;” 
  - rpj;j kUj;Jt Neha;ehly; Neha;Kjy; ehly;  jpul;L 
“ nka;f;Fwp epwk; njhdp tpop eh ,Ukyk; iff;Fwp. 
      - NjiuaH. 
“juzpAs;s tpahjp jd;id al;lhq;fj;jhy; 
jhdwpa Ntz;LtJ NaNjh ntd;dpy; 
jPuzpaNjhH ehb fz;fs; rj;jj;NjhL 
Njfj;jpdJ ghprk; tUzk; ehf;F 
apuzky %j;jpukhkpitf nsl;L 
apjk;gplNt jhd; ghHj;Jf; FwpAq; fz;L 
gudUshy; nghpNahHfs; ghjk; Nghw;wpy; 
gpd;G jtwhky; gz;bjQ; nra;tPNu”     - mfj;jpaH 
Fzthflehb 
Hence the diagnosis is made by the following, 
1. Naadi   (Pulse) 
2. Sparisam ( Sensation to touch) 
3. Naa (Tongue) 
4. Niram (Colour) 
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5. Mozhi (Voice) 
6. Vizhi (Eyes) 
7. Malam ( Faeces) 
         8. Moothiram( Urine) 
 The  speciality of eight tools of diagnosis is mentioned in the following verses also, 
 
“njhFf;fYw;W ml;ltpjg; ghPl;ir jd;idj; 
Jyf;fKwk; gz;bjNu njspthfg; 
gFf;fhpa ehbia eP gbj;Jg; ghUg; 
gfHfpd;w thHj;ijiag; ghH ehitg; ghU 
tFf;fhpa Njfnkdj; njhl;Lg; ghU 
tskhd rhPuj;jpd; epwj;ijg; ghU 
rfpf;fhpa kyj;ijg; ghH ryj;ijg; ghU 
rhHe;j tpopjidg; ghHj;J njsptha;f; fhNz. 
Kabasuram in Relation with Ennvagai Thervugal 
1. Naadi (Pulse): 
clypy; capH jhpj;jpUg;gjw;Ff; fhuzkhd rf;jp vJNth. mJNt jhJ 
my;yJ ehb vdg;gLk; 
 “ehb vd;why; ehbay;y euk;gpy; jhNd 
 eykhfj; Jbf;fpd;w JbjhDky;y 
 ehb vd;why; thj gpj;j rpNyw;gdKky;y 
 ehb vOgj;jPuhapue; jhDky;y 
 ehb vd;why; mz;l Nguz;lnky;yhk; 
 ehb vOtifj; Njhw;wj;Js;sha; epd;w 
 ehbaJah uha;e;J ghHj;jhuhdhy; 
 ehbAWk; nghUs; njhpe;J ehL thNu” 
     - gjpnzz; rpj;jH rjfehb E}y; 
 Naadi is a suitable diagnostic tool used by siddhars. It can be felt one inch 
proximal to the wrist on the radial side by means of palpation with the tip of index, 
middle and ring fingers corresponding vatham, pitham and Kabam respectively. 
The three humours Vatham, Pitham and Kabam exits in the ratio 1:1\2:1\4 
normally.  Dearrangement in these ratios leads to various disease entities. 
The three “Uyir thathukal” are formed by the combination of three naadigal with 
three vayu 
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 a. Edakalai  + Abanan = Vatham. 
 b. Pinkalai  + Piranan = Pitham 
 c. Suzhumunai   + samanan = Kabam 
,Ue;jNghjpYk; Foe;ijfSf;F ehb fzpg;gJ fbdk; vd;gij 
 “nfhz;blNt faNuhfp fhr Nuhfp 
  Fwpg;ghfr; rpw;wpd;gk; nra;j NgHfs; 
 mz;blNt jhpj;jpuHfs; tpUj;jH ghyH 
  md;ghfj; jz;zPhpy; %o;fpNdhHfs; 
 nfhz;blNt ,tHfsJ cWg;gpd; jhJ 
  $wNt KbahJ vtHf;Ff; fpl;Lk; 
 gz;blNt apg;ghPl;ir ahHjhd; fhz;ghH 
  guhguj;jpd; kfpikapJ ghU ghNu” 
- rjf ehb 
vd;Dk; ghlyhy; mwpayhk;. 
In Kabasuram, the following types of Naadi can be seen commonly. They are, 
• Pitha Kabam 
•  Kaba Vatham 
•  Kaba Pitham  
II.    Sparisam: 
Sparisam is a method of palpation and percussion to know the condition of the 
body like warm, fever, chillness, sweating, numbness, parasthesia, dryness of the body, 
erosion patches, ulcers, oedema, emaciation, swelling, obesity and enlargement of liver, 
spleen.In Kabasuram, all patients have Vepam. 
III.  Naa: 
 This is the method of inspection of the tongue mainly gums, teeth, lips, palate etc. 
to find out the colour changes according to vatha, pitha, kaba and mukkutra disease ,by 
noting the tongue’s dryness or wetness, excessive salivation, redness, ulceration, pallor, 
any malignant growth, predominant taste in the tongue, speech and movement of tongue. 
 In Kabasuram, some patients have coated and pale tongue. 
IV. Niram: 
 Colour indicating the vatha, pitha, kaba, mukkutram,yellow, pallor, redness of the 
skin, bluish discoloration of conjunctiva and nail beds are noted. 
 In Kabasuram,no abnormality found. 
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V. Mozhi: 
 Clarity of voice, any disturbances, sound voice, slurring, crying, talk induced by 
hallucination are noted. 
 In Kabasuram,no abnormality found. 
VI. Vizhi: 
Abnormal colour changes indicating the three doshas. Pallor, excessive 
lacrimation, accumulation  of secretion at the angle of eyes, subconjunctival bleeding, 
any specific disease of the eyes are noted. 
In Kabasuram, some patients have pallor of conjunctiva. 
VII. Malam: 
“ky%j;jpuf;Fwp nrg;gpbd; kiyNkw;gFjp tpsf;fhk; 
ikaw;nfhL fizahfpa nkste; fpizahNk 
 kykhdJ Gayhnkdpw; kd;dpw; ngWRuNk 
  kyUq; ftpw;dshy; jd;kf;fs; ngWRuNk 
 kfthd; fhpahdh tJ kwtpd; RukhNk 
  kQ;rl;fpiz ahdtJ kz;zpw; njhL fgNk.” 
       - Njud;itj;jpa kfhfhpry ; 
Quantity, colour, odour, froth, abnormal consistency, indigestion, frequency, 
constipation are noted. 
In Kabasuram, there were loose stools in malakuri. 
VIII Moothiram: 
Quantity, colour, odour, froth, frequency, retention, deposits, presence of 
abnormal constituents such as sugar, protein etc are noted. 
Collection of urine for the determination of Neerkuri and Neikuri, is a special 
diagnostic method. 
Neerkuri and Neikuri 
 “mUe;J khwpujKk; mtpNuhjkjha; 
 m/fy; myHjy; mfhyT+d; jtpHe;jow; 
 Fw;ws tUe;jp cwq;fp itfiw 
 Mbfyrj; jhtpNa fhJ nga; 
 njhU K$hj;jf; fiyFl; gLePhpd; 
 epwf;Fwp nea;f;Fwp epUkpj;jy; flNd.” 
     - Neha;ehly; Neha; Kjy; ehly; jpul;L 
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Prior to the day of urine examination the patient is instructed to take a balanced 
diet and quantities of food must be proportionate to his routine intake. The patient should 
have good sleep. After waking up in the morning, the first urine voided is collected in a 
clear, wide mouthed glass container and is subjected to analysis of “Neerkuri and 
Neikuri” with in one and half an hour.  
 Neerkuri 
“te;j ePHf;fhp iail kzk; Eiu vQ;rnyd; 
iwe;jpa Ysit aiwFJ KiwNa” 
   - rpj;j kUj;Jthq;f RUf;fk; 
VOIDED URINE HAS THE FOLLOWING CHARACTERS 
    1. Niram - Colouration 
 2. Edai  - Specific gravity 
 3. Manam - Smell 
 4. Nurai - Frothy Nature 
 5. Enjal - Quantity of urine voided. 
In Suram,         “Rug;gpzp mhprdj;Njhaq; fhl;LNk” 
   - Neha; ehly; Neha;Kjy;ehly; jpul;L 
vd;gjhy; RuNehapy; kQ;rs;epwk; nghUe;jpa ePH ntspg;gLk; vd;gH 
 
 
 
mrhj;jpa ePH epwk;: 
“RuNkDk; Nkfj;Jdp NaDk; ,Uf;fpy; 
ngUfpa %j;jpuk; gphpf;Fk; capiuNa. 
     - Neha;ehly; Neha;Kjy;ehly; jpul;L 
 vd;gjhy; Ruk; my;yJ NkfNeha; fz;bUf;Fk;NghJ mjpfhpj;j ePH capiug; 
Nghf;Fnkd mwpayhk;. 
Neikuri: 
The speciality of neikuri is stated in the following verse, 
 “If;Fwp nfhLtl thdpo ykHe;NjhH 
 iff;Fwp njhpj;j eq;flTisj; Jjpj;Nj 
 nka;f;Fwp epwe;njhdp tpop ehtpU kyk; 
 iff;Fwp KotJ} cq;fw;whH jk;kpDk; 
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 ngha;f;Fwp nka;f;Fwp GfYnk tHf;Fk; 
 nea;f;Fwp ajid ape;ePzpyj; Jiug;Nghk;” 
   - rpj;j kUj;Jt Neha; ehly; Neha; Kjy;ehly; jpul;L 
The process of dropped gingely oil indication, 
 epwf;Fwpf; Fiuj;j epUkh zePhpw; 
 rpwf;f ntz;nza; NahH rpWJsp eLtpLj; 
 njd;Wwj; jpwe;njhyp Nafhjikj;jjp 
 dpd;wjptiy Nghk; newp tpopawpTk; 
 nrd;wJ GfYQ; nra;jpia AzNu. 
- rpj;j kUj;Jt Neha; ehly; Neha; Kjy;ehly; jpul;L 
The collected specimen as said above is to be analysed by following method. The 
specimen is kept open in a glass dish. It is to be examined under direct sunlight, without 
any shaking of the vessel. Then add on drop of gingely oil by at distance of 1\2 or ¾    
inch height, observe keenly the direction in which it spreads within few minutes, and 
conclude the diagnosis as follows, 
“muntd ePz;bd; m/Nj thjk; 
MopNghy; gutpd; m/Nj gpj;jk; 
Kj;njhj;J epw;fpd; nkhoptnjd; fgNk 
mutpy; MopAk; Mopapy; muTk; 
mutpy; Kj;Jk; Mopapy; Kj;Jk;.” 
 - rpj;j kUj;Jt Neha;ehly; Neha; Kjy; ehly; jpul;L 
 
ghk;GNghy; gutpdhy; thjk; vd;Wk;, 
Nkhjpuk; Nghy; gutpdhy; gpj;jk; vd;Wk;, 
Kj;njhj;J epd;why; fgk; vd;Wk; mwpayhk; 
 
Paruvakaalam (Seasonal Variations) 
 The whole year is constituted by six seasons. They are, 
S.No Kaalam Kuttram State of Kuttram Suvai 
1. Kaar Kaalam 
(Aavani-Puratasi) 
(Aug16 – Oct 15) 
Vatham ↑↑ 
Pitham ↑ 
Vettrunilai Valarchi. 
Thannilai Valarchi 
Enippu 
Pulippu 
Uppu. 
2. Koothir Kaalam Vatham (−) Thannilai Adaithal Enippu 
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Iypasi – Karthigai 
(Oct16 – Dec15) 
Pitham ↑↑ 
 
Vettrunilai Valarchi. 
 
Kaippu  
Thuvarppu 
3. Munpani Kaalam 
( Markazhi – Thai) 
(Dec16 – Feb15) 
Pitham (−) Thannilai Adaithal 
 
Enippu 
Pulippu 
Uppu 
4. Pinpani Kaalam 
(Masi – Panguni) 
(Feb16 – Apr15) 
Kabam ↑ 
 
Thannilai Valarchi. Enippu 
Pulippu 
Thuvarppu 
5. Elavenil Kaalam 
(Chithirai – Vaikasi) 
(Apr16 – Jun15) 
Kabam ↑↑ Vettrunilai Valarchi. 
 
Kaippu 
Karppu 
Thuvarppu 
6. Mudhuvenil Kaalam 
(Aaani – Aadi) 
(Jun16 – Aug15) 
Vatham ↑ 
Kabam (−) 
Thannilai Valarchi 
Thannilai Adaithal 
 
 
Enippu 
The incidence of Kabasuram is predominant in Karkaalam and Koothirkalam. 
FIVE TYPES OF LANDS  It is divided into five types. 
1. Kurinji : Mountain regions and surroundings. 
2. Mullai : Forest regions and surroundings. 
3. Marutham : Cultivating regions and surroundings. 
4. Neithal : Sea and Coastal regions. 
5. Palai : Desert land only. 
Most of the sufferers of Kabasuram belongs to Neithal Thinai and Kurinji 
 
UDAL KATTUGAL 
 
1.  Saaram  : It gives strength to the body and mind . 
2.  Senneer  : Saaram after absorption is converted into senneer.  It is  
responsible for knowledge, strength, boldness, and healthy 
complexion. 
3.  Oon  : Gives structure and shape to the body and is responsible for  
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the movement of the body. 
4.  Kozhuppu  : Lubricates the organs to proceed on it own works 
5.  Enbu  : Protects the vital organs and used for movements and  
nominates body structure. 
6.  Moolai  : Present inside the bones and it gives strength and maintain  
the normal condition of the bone. 
7.  Sukkilam (or) : Responsible for the reproductive functions of species. 
 Suronitham 
 
Among these 7 Udal kattugal, saaram gets affected in patients with Kabasuram. 
 In some patients senneer is also affected. 
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Mukkutram 
 Human body is influenced by Three doshas (ie) Vatham, Pitham and Kabam.  
They are responsible for normal physiological condition of the body. 
Vatham: 
Sl.No Udal Kattugal Increased Conditions Decreased Conditions 
1. Saaram 
Leads to diseases identical to 
the increase in Kaba like 
loss of appetite, excessive 
salivation 
Loss of Weight, tiredness, dryness 
of skin, laziness, diminished 
activity of the sense organs 
2. Senneer 
Boils and tumours in 
different parts of the body, 
splenomegaly, Colic pain, 
icreased blood pressure, 
reddish eye and skin, 
jaundice, leprosy, 
haematuria etc 
Tiredness, Lassitude, anaemia 
3. Oon 
Tumours or extra growth 
around the neck, face 
abdomen, thigh, genitalia etc 
Muscle wasting 
4. Kozhuppu  
Identical to that of increased 
oon associated with 
dyspnoea and loss of activity 
Pain 
5. Enbu Strong bones and teeth Weak bones, teeth, nails and hairs 
6. Moolai 
Heaviness, swollen eyes, 
swollen phalanges, oliguria 
and non – healing ulcers 
Osteoporosis and shunken eyes. 
7. 
Sukkilam (or) 
Suronitham 
Increased sexual activity and 
signs identical to urinary 
calculi 
Failure to reproduce, pain in 
genitalia etc. 
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 Vatham is a kinetic energy, which influences all movements. 
 Vatham is located in the abanan, idakalai, faeces, spermatic cord, iliac bone, skin, 
nerves, joints, hair foliclles, muscles, bone, ear and thigh. 
Sl.No Name Locations Physiologic Functions 
1. Piranan Heart, Lower and 
Upper Respiratory 
Tracts 
Controls knowledge, mind and five 
objects of sense, useful for breathing 
2. Abanan Lower abdomen and 
extremities 
Responsible for urination, expels 
faeces and foetus, discharge sperm 
and menstruation. 
3. Viyanan Mainly at heart Responsible for movement of all parts 
of the body and used to feel the 
sensation 
4. Uthanan Chest Responsible for vomiting, cough, 
hiccough, sneezing 
5. Samanan Stomach Aids for proper digestion.  It controls 
the activity of other vayus 
6. Naagan Eyes Responsible for opening and closing 
of the eyes 
7. Koorman Heart and Eyes Responsible for vision and yawning 
and controls lacrimation 
8. Kirukaran Throat Responsible for salivation nasal 
secretion and appetite 
9. Thevathathan Eruvai & Karuvai For laziness, sleeping and anger 
10. Thananjeyan Nose Responsible for bloating of the body 
after death.  It escapes on the third day 
after death through the cranium when 
it bursts. 
In the case of Kabasuram. 
1. Pranan   - Cough expectoration, breathlessness. 
2.  Abanan  - Loose stools. 
3. Uthanan  - Vomiting. 
4. Samanan  - Due to other vayus it is affected  
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5. Kirukaran  - Loss of appetite 
 The above vayus are affected commonly. 
Pitham: 
 Pitham is responsible for all the transformation.  Pitham is located in urinary 
bladder, heart, head, umbilicus, abdomen, blood, sweat, skin and eyes. 
Pitham is classified into 5 types.  They are, 
1. Anal Pitham  - Responsible for digestion of food. 
2. Ranjaga pitham - Responsible for colour of blood. 
3. Sathagam  - Located in heart and is responsible for normal 
     activities of the body. 
4. Alosagam  - Responsbile for normal vision 
5. Prasagam  - Responsible for the complexion of skin. 
In case of Kabasuram 
1. Anal Pitham  - Loss of appetite 
2. Ranjagam  - Paleness of the conjunctiva and tongue 
3. Sathagam  - difficulty to do the routine works properly  
The above vayus are affected commonly 
Kabam 
 Stabilizes, maintains and lubricates all movements. 
 Kabam is found in samanan, semen, brain, head, tongue, nose, bones, bone 
marrow, fat, nerves, chest, blood, large intestine, eye, stomach and pancreas. 
 Kabam is classified in to 5 types, they are. 
1. Avalambagam : Heart is the center for Avalambagam,  It controls all other  
    forms of kabam. 
2. Kilethagam : Stomach is the center for kilethagam.  It give moisture and  
softness to the ingested food and helps for digestion. 
3. Pothagam : Tongue is the center for pothagam and it is responsible for  
the sense of taste. 
4. Tharpagam : Head is the center for tharpagam.  It gives cooling effect to  
eyes. 
5. Santhigam : It lies in the joints and is responsible for the locomotive  
action of movable bony joints. 
In Case of Kaba Suram, the following Kabam were affected. 
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1. Avalambagam - Cough with expectoriation. 
2. Kilethagam - Loss of appetite. 
3. Santhigam  - Arthralgia. 
Abnormal functions of Vatham 
 Pain in the wholebody, twitching, piercing pain, inflammation, red coloured 
complexion and also roughness of the skin.Hardness of the limbs, astringent, taste, 
sweating, and numbness or paralysis of the limb, tremors, muscular wasting, severe pain, 
decrease in the amount of excretion of stools and urine, thirst, blackish discolouration of 
the skin, stools, urine.  
Abnormal functions of Pitham 
 Indigestion, hyper acidity burning sensation over the stomach, chest and throat. 
Abnormal functions of Kabam 
 Pale skin complexion, cold, itching, dullness, heaviness, oilyness, loss of 
sensation, a sense of sweetness in mouth. 
 
Humor Increase Decrease 
Vatham Distended abdomen, 
Constipation, 
Weakness, 
Insomnia 
Tremors 
Breathlessness 
Blackish discolouration 
Body pain,  
Feeble Voice, 
Syncope, 
Diminished capability of 
brain 
Pitham Yellowish discolouration of eyes, skin, urine 
and motion 
Polyphagia  
Polydypsia 
Burning sensation all over the body 
Sleeplessness 
Cold, 
Pallor, 
Decreased appetite 
 
Kabam Loss of appetite, 
Excessive salivation, 
Heaviness, 
Prominence of bone edges, 
Dry cough, 
Lightness 
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Dyspnoea, 
Excessive sleeping, 
Whiteness, 
Diminished activity. 
Profuse sweating,  
Palpitation, 
Giddiness, 
Dryness of joints 
 
Relation between Suvai, Panjabootha and Mukkutram 
Sl.No Suvai Panjabootha Mukkutram 
1. Enippu 
(Sweet) 
Piruthivi + Appu Kaba ↑ 
Vatha  ↓ (-) 
Pitha   ↓ (-) 
2. Pulippu 
(Sour) 
Piruthivi + Theyu Kaba ↑ 
Pitha   ↑ 
Vatha  ↓ (-) 
3. Uppu (Salty) Appu + Theyu Kaba ↑ 
Pitha   ↑ 
Vatha  ↓ (-) 
4. Kaippu (Bitter) Vayu + Space Vatha  ↑ 
Kaba ↓ (-) 
Pitha   ↓ (-) 
5. Karppu (Pungent) Vayu + Theyu Vatha  ↑ 
Pitha   ↑ 
Kaba ↓ (-) 
6. Thuvarppu 
(Astringent) 
Piruthivi + Vayu Vatha   ↑ 
Kaba ↓ (-) 
Pitha   ↓ (-) 
↑ - Valarchi 
↓  - Samappaduthuthal 
Udal Vanmai – Body Immunity 
 The Udal Vanmai is classified into 3 types.  They are, 
1) Iyarkai Vanmai 
2) Seyarkai Vanmai 
3) Kaala Vanmai 
1.  Iyarkai Vanmai 
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 Natural immunity of the body itself by birth 
2.  Seyarkai Vanmai 
 Improving the health by intake of nutritious food materials, activities and 
medicines. 
3. Kaala Vanmai 
 Development of immunity according to age and the environment. 
 When Udal Vanmai is affected there may be a possibility of Kabasuram. 
Gnanenthiriyam 
 Gnanenthiriyam are Mei, Vai, Kan, Mooku and Sevi. 
1.   Mei   : Feels all types of sensation. 
2. Vai   : For recognizing taste 
3. Kann   : Meant for vision 
4. Mooku   : For recognizing smell 
5. Sevi   : For hearing. 
 In case of “Kabasuram” no abnormality was found  
Kanmenthriyam: 
Kanmenthriyam are kai, Kaal, vaai, eruvaai and karuvaai. 
1. Kai   : Majority of normal works done by hands 
2. Kaal   : For walking 
3. Vaai   : For Speaking 
4. Eruvaai  : For defecation 
5. Karuvaai  : For reproduction 
 In case of ‘Kabasuram’ no abnormality was found. 
Maruthuvam 
Line of Treatment: 
 Siddha treatment is not only for complete healing but also prevention and 
rejuvenation.  Saint Thiruvalluvar says about physician duty,  study the disease, study the 
cause, treat subsiding way and do what is proper and effect. 
 “Neha; ehb Neha; Kjy; ehb mJ jzpf;Fk; 
 tha;ehb tha;g;gr; nray;. 
 “cw;whd sTk; gzpasTq; fhyKq; 
 fw;whd; fUjpr; nray;.” 
     - jpUf;Fws; 
 So it is essntial to know the disease, the aetiology, the nature of patients, severity 
of the illness, the seasons and the time of occurrence must be observed clearly. 
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Line of treatment is as follows. 
1. Kaappu (prevention) 
2. Neekkam (Treatment) 
3. Niraivu (Restoration) 
1.  Kaappu (Prevention): 
As per Siddha system even during the time of conception the vinaipayan is 
transferred into the fertilized embryo, which is the aetiology for certain diseases and may 
be cured not only be medicines but by teaching the following habits. 
1. Teaching good moral habits. 
2. Avoid stress and strain. 
3. Always have good mental thoughts by doing meditation. 
4. Yoga 
2. Neekam (Treatment) 
 The aim of treatment is based on, 
a. To bring the three doshas into normal equilibrium state, emetics and purgatives 
are given.  But the children is already weak.  So administration of purgatives and 
emetics is excluded from line of treatment. 
b. To treat the patient according to the symptoms by internal medicine. 
1.Surakudari  mathirai –  1/2 to 1 tab B.D 
2. Kabasura Kudineer – 15 to 30 ml. 
Pathiyam: 
 During the course of treatment, the drug is administered to the patients according 
to the nature of disease and the patients were advised to follow certain restrictions 
regarding diet and physical activities. 
 This type of medical advice in siddha system of medicine is termed as 
“Pathiyam”. Importance of pathiyam is quoated as follows. 
 “gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
 gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy;  
 gj;jpaNk ntw;wpjUk; gz;bjHf;F Mjypdhy; 
 gj;jpaNk cj;jpnad;W ghH” 
- NjiuaH ntz;gh 
The patient with Kabasuram was advised to avoid cool drinks, cold water and 
exposure to chill weather. 
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3.  Niraivu: (Restoration) 
1. Reassurance of disease recovery was given to all patients 
2. All the patients were advised to live in good health free from disease 
Diet: 
 “kUe;Nj czT czNt kUe;J” 
- jpU%yH 
“khWghb y;yhj cz;b kWj;Jz;zpd; 
CWgh by;iy capHf;F” 
- jpUf;Fws; 
vd;gjpdhy,; cz;Zk; cztg; nghUspYk; ftdk; nrYj;j Ntz;Lk;. 
FspHe;j nghUl;fisj; jtpHf;f Ntz;Lk;.  FspHe;j fhw;W, FspHgdpapy; 
cyhTtij jtpHf;f Ntz;Lk;. 
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  MODERN ASPECTS 
ACUTE BRONCHITIS 
 Kabasuram more or less resembles acute bronchitis in modern medicine. The 
signs and symptoms of kabasuram can be corelated with the clinical features of acute 
bronchitis which is briefly disussed as follows.  
 Bronchitis is an  inflammation of the large bronchi of the lungs. 
 
Definition:  
Acute bronchitis is characterized by cough and sputum (phlegm) production and 
symptoms related to the obstruction of the airways by the inflamed airways and the 
phlegm, such as shortness of breath and wheezing.  
Acute bronchitis is an infection of the bronchial tree. The bronchial tree is made 
up of the tubes that carry air into lungs. When these tubes get infected, they swell and 
mucus forms inside them. This makes it hard to breathe. It cause coughs up mucus & 
wheeze. 
In the past, bronchitis was a term reserved for children who cough with viral 
respiratory tract infections and who may also wheeze. 
 Acute bronchitis is probably best defined as cough with rhonchi or coarse crackles 
that clear with coughing and no evidence of pneumonia. 
 
Description 
 Acute bronchitis occurs most frequently during the winter. It often follows a viral 
infection such as cold or the flu, and may accompany a bacterial infection. 
 Acute bronchitis more commonly affects younger than older children and boys 
more often than the girls. The prevalence of bronchitis varies with age.  
 A person who has acute bronchitis is usually better within two weeks. The cough 
that accompanies the disease may last longer however, as with similar infections of the 
airways, pneumonia may also develop. 
 Anyone can get acute bronchitis. However, people with weak immune systems, 
such as infants & the elderly, are more prone to the disease.  
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Pathogenesis 
 Acute bronchitis is characterized by infection of the terminal bronchia. Infection 
and inflammation produces bronchial edema and mucus production. For more virulent 
viruses such as influenza and adenovirus, cough may result from the destruction of the 
lower respiratory epithelium, which may be   extensive. For less virulent viruses such as 
common cold viruses, it is postulated that activation of inflammatory mediators and 
altered bronchial mucociliary function play a more important role..  
 
Typical viruses:  
Respiratory syncytial virus, rhinovirus, influenza.  
 
Causes and Risk factors 
 The most common viruses associated with bronchitis are influenza virus types A 
and B that cause influenza, and rhinovirus, para influenza, and coronavirus, which cause 
the common cold.  
 Bacterial infection with Mycoplasma pneumoniae, Clamydiae pnemmoniae and 
Bordetella pertussis, particularly in young adults, can lead to acute bronchitis.  
The causes of acute bronchitis are primarily infectious and mostly viral.  The most 
commonly associated infectious agents of acute bronchitis in early childhood are 
respiratory syncytial virus (RSV), influenza virus, and para influenza virus types 1 and 3. 
 Adenovirus may cause disease, especially in young children.  After 5 years of age 
mycoplasma pneumonia is common, becoming the most commonly isolated infectious 
agent causing bronchitis among persons 6 – 20 years of age. 
 Acute bronchitis is almost always caused by viruses that attack the lining of the 
bronchial tree and cause infection.  Body fights back against these viruses, more swelling 
occurs and more mucus is made.  It takes time for body to kill the viruses and heal the 
damage to bronchial tubes. 
 In most cases the same viruses that cause cold cause acute bronchitis.  Research 
has shown that bacterial infection is a much less common cause of bronchitis.  Very 
rarely, an infection caused by a fungus can cause acute bronchitis. 
 Multiple epidemiologic studies have demonstrated that viruses produce most 
attack of acute bronchitis.  Rhinovirus is the organism most frequently recovered from 
children with actute bronchitis, particularly those whose disease is associated with 
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wheezing.  Respiratory syncytial virus, influenza, para influenza,, adeno virus and the 
para myxoviruses have also been identified. 
 Rubeola is almost universally associated with acute bronchitis, the respiratory 
symptoms often preceding the more classic manifestations of this infection. 
 Onset of viral bronchitis is usually gradual with cough appearing three to four 
days after the rhinitis.  The presence of cough denotes extension of the infection to the 
trachea and bronchi.  The cough is initially non – productive, but several days into the 
illness it may evolve into a loose, gurgly cough with production.  The younger child 
generally swallows the mucus.  Vomiting associated with coughing paroxysms can occur.  
The vomitus frequently contains mucus, confirming the productive nature of the cough. 
 Auscultation of the chest is frequently unremarkable in the early stages.  Rhonchi 
may be heard as the cough progresses.  Rales are infrequent. 
 With the exception of the bronchitis associated with Bordetella pertusis, 
mycobacterium tuberculosis corynebacterium diphtheria and mycoplasma pneumoniae 
primary bacterial trachobronchitis seems to be quite rare.  The incidence of secondary 
bacterial infection following a viral bronchitis is difficult to determine. 
 Streptococus pneumoniae, staphylococcus aureus, and haemophilus influenzae 
have been implicated as etiologic agents, but because these organisms can be found in 
oral pharynx, their presence is not always proof of disease. 
Risk factors 
 Air pollutants  
 Allergies 
 Chronic sinusitis 
 Lack of pertussis immunization.  
 Smoke inhalation. 
 Low Birth Weight 
 Malnutrition 
 Indoor Pollution 
Signs and symptoms 
 The first sign of bronchitis is usually a persistent dry cough (associated with 
upper respiratory infection). Eventually, coughing brings up sputum from the lungs that 
may be thin, clear and white. As infection progresses, the sputum becomes thick and 
yellow, green or brown.  
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Other symptoms include the following 
 Burning pain, wheezing and crackling in the chest. 
 Painful and difficult breathing. 
 Malaise 
 Fever. 
 Insomnia may develop with persistent nighttime coughing. Symptoms usually last 
3 to 7 days; a dry cough commonly persists several weeks after the infection resolves.  
Prognosis 
 Acute bronchitis usually lasts a few days. It may accompany or closely follow a 
cold or the flu, or may occur on its own. Bronchitis usually begins with a dry cough, 
including waking the sufferer at night. After a few days it progresses to a wetter or 
productive cough, which may be accompanied by fever, fatigue and headache. The fever, 
fatigue and malaise may last only a few days; but the wet cough may last up to several 
weeks.  
Acute bronchitis may lead to asthma (or) pneumonia.  
Physical Examinations 
Inspection  
 Movement of chest wall normal or symmetrically diminished 
 Mediastinal displacement none 
Palpation 
 Vocal resonance – normal 
Percussion  
 Normal 
Auscultation 
 Breath sounds – Vesicular with prolonged expiration 
 Added Sound – Rhonchi, usually with some coarse crepitations. 
Diagnosis:  
 A physical examination will often reveal decreased intensity of breath sounds, 
wheezing, rhonchi and prolonged expiration.  
 A variety of tests may be performed in patients presenting with cough and 
shortness of breath.  
 A blood test would indicate inflammation (as indicated by a raised WBC count) 
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 Neutrophils infiltrate the lung tissue, aided by damage to the airways caused by 
irritation.  
 Damage caused by the irritation of the airways leads to inflammation and leads to 
neutrophills being present.  
 Mucosal hypersecretion is promoted by a substance released by neutrophills.  
 Further obstruction to the airways is caused by more goblet cells in the small 
airways. This is typical of chronic bronchitis. 
 Chest x- rays are indicated only if there is any suspicion of pneumonia based on 
history or physical exam. 
Complications: 
 Left untreated, acute bronchitis can occasionally progress to pneumonia and 
chronicbronchitis, particularly in people with suppressed immune systems or lung 
disease. 
 Chronic bronchitis is associated with long- term constriction, and other diseases, 
including asthma, emphysema and chronic obstructive pulmonary disease. 
Differential Diagnosis  
 Pneumonia 
 Asthma 
 Acute exacerbation of chronic bronchitis 
 Pertussis 
            Postnasal drip  
 Reflux 
 Aspiration of foreign body. 
Treatment 
   Acute bronchitis is generally mild disorders that responds to supportive measures. 
 Supportive measures include rest, hydration, and humidification of inspired air, 
avoidance of respiratory irritants (e.g. Cigarette smoke), antipyretics and bronchodilators 
for those with wheezing. 
 Persistent coughing with gagging and vomiting can precipitate dehydration and 
serum metabolic changes.  Monitoring of these parameters in the severely affected host 
and reconstitution of deficits by oral or parenteral rehydration are indicated. 
 Specific antimicrobial therapy can be provided when Haemophilus influenza or 
streptococcus pneumoniae is isolated. 
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OBSERVATION AND RESULTS 
 
 For the clinical study, 50 cases were selected, 30 cases treated in OPD and 20 
cases in IP  of Ayothidoss Pandithar Hospital of National Institute of Siddha, Chennai-47  
Results were observed with respect to the following criteria, 
1. Age distribution. 
2. Sex distribution 
3. Paruvam Distribution 
4. Diet Habits 
5. Religion Distribution 
6. Socio – economic status 
7. Family history 
8. Thinai reference 
9. Seasonal Reference 
10. Distribution of three dosham 
11. Udal kattugal reference 
12. Envagai Thervugal 
13. Neerkuri, Neikuri reference 
14. Clinical features 
15. Results after treatment.  
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Table – 1: Age - Gender distribution of 50cases (30 cases in OP & 20 
cases in IP) of Kabasuram. 
 
Gender Age 
(Yr) Male Female 
Total 
3– 4 
5 – 6 
7 – 8 
9 – 10 
10 – 12 
4 
         5 
6 
4 
10 
3 
3 
4 
5 
6 
7 
8 
10 
9 
16 
 29 21 50 
 
 
Out of 50cases taken for clinical trial most of the cases were in 11-12 age group 
 
 
 
4
3
5
3
6
4 4
5
10
6
0
5
10
15
3--4 5--6 7--8 9--10 11--12
Age Distribution
Male Female
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 Table.2. Sex Reference of 50cases (30 cases in OP & 20 cases in IP) of 
Kabasuram. 
       
1020
5
15
25
Male Female
Sex Distribution OPD
Male Female
     
 
 
 
11
95
25
Male Female
Sex Distribution IPD
Male Female
                                                                                       
 
Out of 50 cases, 56% were males and 42% were females.  So this disease can affect either 
sex. 
 
Table: 3 Paruvam Distribution of 50 cases of Kabasuram. 
a. Male Children: 
 
Sl.No Paruvam No. of cases Percentage 
1. 
 
 
 
2. 
 
Ambuli, Sitril, Siru parai, Siru ther paruvam (3-
5yr) 
 
Siru, Valiba Paruvam  
(5-12yr) 
 
8 
 
 
21 
 
27 
 
 
73 
 
 
 
Sl.No Sex 
No. of 
cases 
% 
1. 
2. 
Male 
Female 
20 
10 
66 
34 
 Total 30 100 
Sl.No Sex 
No. of 
cases 
% 
1. 
2. 
Male 
Female 
9 
11 
45 
55 
 Total 20 100 
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a. Female Children 
 
Sl.No Paruvam No. of cases Percentage 
1. 
 
 
 
2. 
 
Ambuli, Ammanai, Neer --aduthal, Uonjal  
(3-5yr) 
 
Pethai, Pethumbai, Mangai Paruvam  
(5 – 12 yr) 
 
4 
 
 
17 
 
20 
 
 
80 
 
The clinical study reveled that the incidence of the disease was high in male than female 
children. 
 
Table: 4 Diet Habits of 50 cases of Kabasuram. 
 
 
 
 
 
 
 
 
 
 
Out of 50 cases 20% were taking vegetarian diet, 80% were taking non – vegetarian diet. 
 
 
Table – 5: Religion of 50 cases of Kabasuram. 
 
 
Sl.No Religion No. of cases Percentage 
1. 
2. 
3 
Hindu 
Christian 
Muslim 
37 
2 
11 
74 
4 
22 
 Total 50 100 
 
Out of 50 cases 74% of cases were Hindus, 4% of cases were Christians and 22% 
of cases were Muslims. 
 
Sl.No Diet Habits 
No. of 
cases 
% 
1. 
2. 
Vegetarian 
Non – Vegetarian 
10 
40 
20 
80 
 Total 50 100 
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Table: 6 : Socio – Economic Status of 50 cases of Kabasuram. 
  
Sl.No Economic No. of cases Percentage 
1. 
2. 
3 
Poor 
Middle 
Rich 
35 
11 
4 
70 
22 
8 
 Total 50 100 
 
 
Socio Economic Status
8%
22%
70%
Rich Middle Poor
 
 
Out of 50 cases 70% of cases were poor, 22% of cases were middle and 8% of cases were 
rich class. 
 
Table 7: Family History of 50 cases of Kabasuram. 
 
Sl.No Family History No. of cases Percentage 
1. 
2. 
Present 
Absent 
33 
17 
 66 
34 
 Total 50 100 
  
 
Out  of 50 cases treated, 66% cases had positive family history and 34% had no family 
history 
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Family Histroy
66%
34%
Present Absent
 
 
 
 
Table 8: Thinai Reference of 50 cases of Kabasuram. 
 
 
 
 
 
 
 
 
 
Out of 50 cases 26%in Kurinji,36% in Mullai,16% in Marutham and  12 % of 
cases in Neithal Nilam. Siddha literature mentioned that Kaba diseases are more common 
in peoples dwelling in Kurinji nilam. 
Sl.No Thinai History No. of cases Percentage 
1. 
2. 
3 
4. 
5. 
Kurinji 
Mullai 
Marutham 
Neithal 
Paalai 
13 
18 
8 
6 
- 
26 
36 
16 
12 
- 
 
 Total 50 100 
 50  
 
Table 9: Seasonal Reference of 50 cases of  Kabasuram. 
 
Sl.No Season No. of cases Percentage 
1. 
2. 
3 
4. 
5. 
6 
Karkaalam 
Koothirkaalam 
Munpanikaalam 
Pinpanikalaam 
Elavenil Kalaam 
Mudhuvenil Kaalam 
11 
39 
- 
- 
 
- 
 
- 
22 
78 
- 
- 
 
             - 
 
- 
 Total 50 100 
 
Out of 50 cases 78% cases in Koothirkalam, 22% in Karkalam. 
 
 
 
 
 
 
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
Kurinji Mullai Marutham Neithal Paalai
NO OF CASES 
THINAI REFERENCE 
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Table 10: Distribution of Three Doshasm of 50 cases of Kabasuram. 
A. Table illustrating the dearrangement of Vatham 
 
Sl.No Classification of 
vatham 
No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7 
8. 
9. 
10 
Pranan 
Abanan 
Viyanan 
Uthanan 
Samanan 
Nagan 
Koorrman 
Kirukaran 
Dhevathathan 
Thananjeyan 
50 
11 
25 
7 
36 
- 
- 
36 
50 
- 
100 
22 
25 
14 
72 
- 
- 
72 
100 
- 
 
VATHAM
100%
22%
25%
14%
72%
72%
100%
Pranan Abanan Viyanan Uthanan Samanan Kirukaran Dhevathathan
            
In Vatham all cases had dearrangement in Pranan & Dhevathathan, 25 in Viyanan,36 
cases in Samanan & Kirukaran, 11 in  Abanan and 7 in Udhanan. 
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B.Table illustrating the dearrangement of pitham.  
 
Sl.No Classification of Pitham No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
 
Anal pitham 
Ranjagam 
Saathagam 
Prasagam 
Alosagam 
36 
13 
50 
- 
- 
72 
26 
100 
- 
- 
 
 
3 6
1 3
5 0
0 0
0
5
1 0
1 5
2 0
2 5
3 0
3 5
4 0
4 5
5 0
N O . O F  C A S E S
A n a l  p i t h a m R a n j a g a m S a a t h a g a m P r a s a g a m A l o s a g a m
C L A S S IF I C A T I O N  O F  P IT H A M
 
 
 
 In Pitham all cases has dearrangement in Saathagam, 36 cases in Anal Pitham and 
13 cases in Ranjagam. 
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C. Table illustrating the derarrangement of Kabam 
 
                     
 
 
 
 
 
 
 
 
 
 
 
 
  
 
In Kabam, all cases had dearrangement in Avalambagam,  36  cases had 
dearrangement in Kilethegam and 25 cases had derangements in Santhigam. 
 
Sl.No Classification of Kabam 
No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
 
Avalambagam 
Kilethegam 
Pothagam 
Tharpagam 
Santhigam 
50 
36 
- 
- 
25 
100 
72 
- 
- 
50 
50 
36 
0 0 
25 
0 
5 
10
15
20
25
30
35
40
45
50
NO. OF CASES
Avalambagam Kilethegam Pothagam Tharpagam Santhigam
CLASSIFICATION OF KABAM 
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Table. 11. Udal Kattugal Reference of 50 cases of Kabasuram. 
The seven thathus which contribute for the body structure and functions, get 
altered accordingly in pathological condition.  Hence in Kabasuram the following 
observations were tabulated as follows, 
 
Sl.No Types No. of cases Percentage 
1. 
2. 
3. 
4. 
5 
6. 
7. 
 
Saaram 
Senneer 
Oon 
Kozhuppu 
Enbu 
Moolai 
Sukkilam / 
Suronitham 
50 
13 
- 
- 
- 
- 
- 
- 
100 
26 
- 
- 
- 
- 
- 
- 
 
100% of cases had dearrangement in Saaram.  26% of cases had dearrangement in 
Senneer. 
Table: 12 Envagai Theruvugal of 50 cases of Kabasuram. 
In Siddha system, the eight types of investigation were emphasized much for 
clinical approach and diagnosis.  Hence the rules were strictly followed and the 
observation tabulated here. 
Sl.No Types No. of cases Percentage 
1. 
2. 
3. 
4. 
5 
6. 
7. 
 
Naa 
Niram 
Mozhi 
Vizhi 
Sparisam 
Malam 
Moothiram 
 
30 
- 
- 
13 
50 
22 
- 
60 
- 
- 
26 
100 
44 
- 
8. Naadi  
a..Vatha pitham 
b. Pitha Vatham                         
c. Pitha Kabam 
 
 
23 
16 
11 
 
46 
32 
22 
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Naa was affected in 60% cases. 
 Vizhi was affected in26% of cases. 
 Sparisam were affected in all the 50 cases. 
 Malam was affected in 22% of cases. 
 Naadi: 
o Vatha Pitha naadi in23 cases. 
o Pitha Vatha naadi in 16 cases. 
o Pitha Kabam naadi in11 cases. 
Table No: 13. Neerkuri, Neikuri Reference of 50 cases of Kabasuram. 
Sl.No Types No. of cases Percentage 
I. NEERKURI 
Vaikol Niram 
 
50 
 
100 
II. NEIKURI 
Spreading like snake 
Like Ring 
Like Pearl 
 
10 
18 
22 
 
20 
36 
44 
 
 
  
Regarding moothiram, Neerkuri showed straw coloured urine in all cases, Neikuri 
showed Kabam neer in 44% cases, 36% cases had Pithaneer and 20% cases had 
Vathaneer. 
                  
            
             NEIKURI 
         
N E I K U R I
0
5
1 0
1 5
2 0
2 5
S p r e a d i n g  l i k e
s n a k e
L i k e  R i n g L i k e  P e a r l
NO
 
O
F 
CA
SE
S
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Table : 14    Clinical Features of  50 cases of Kabasuram. 
 
 
Sl.No Clinical features No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
6 
7. 
8. 
Fever 
Cough with expectoration 
Night Cough 
Wheezing 
Breathlessness 
Arthralgia 
Fatigue 
Constipation 
          50 
50 
8 
6 
34 
25 
50 
11 
100 
100 
16 
12 
68 
50 
        100 
         22 
 
CLINICAL FEATURES
100%
100%
16%12%68%
50%
100%
22%
Fever Cough with expectoriation night cough
Wheezing Breathlessness Arthralgia
Fatigue Constipation
 
 
 All 50  cases were affected by fever , cough with  expectoration and fatigue,34 
cases were affected by breathlessness , 8 cases  were affected by night cough,constipation 
in 11 and 25 cases were affected by  arthralgia. 
 
 
 
 57  
 
Table: 15 Result after treatment of 50 cases of Kabasuram. 
 
 
Sl.No Results No of cases Percentage 
1. 
2. 
3. 
Good Relief 
Moderate Relief 
Mild Relief 
35 
10 
5 
70 
20 
10 
 Total 50 100 
 
         
Results
70%
20%
10%
Good Relief Moderate Relief Mild Relief
 
 
                                                     
 
               70% of cases had good relief.  20% of cases had moderate relief.  10% of cases 
had mild relief. 
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          DISCUSSION 
Kabasuram is a common pediatric problem. This disease has been clearly 
described in several siddha texts.  Kabasuram more or less resembles Acute bronchitis in 
modern medicine. 
 In this study several cases were diagnosed at O.P.and I.P according to clinical 
features mentioned in siddha texts.  Siddha method of diagnosis were carried out and 
recorded in proforma with the help of modern investigations. 
 The diagnosis was confirmed and the patients were treated with the drug  Sura 
kudari Mathirai and Kaba sura kudineer.From the results and observations as mentioned 
in previous part discussions was made out. 
Age Distribution 
 The incidence of Kabasuram was more predominant in children with the age 
group of 11-12. 
Sex Distribution 
 Out of 50 cases, 56% were males and 42% were females.  So this disease can 
affect either sex. 
Paruvam Distribution 
 The clinical study reveled that the incidence of the disease was slightly high in 
female than male children. 
Diet Habits 
 Out of 50 cases 20% patients were vegetarian 80% patients were non – 
vegetarian. 
Religion Distribution 
 Out of 50 cases 74% cases were Hindus, 4% cases were Christians and 22% cases 
were Muslims. 
Socio Economic Status 
 Out of 50 cases 70% cases were poor, 22% cases were middle and 8% cases were rich 
class. 
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Family History 
 Out of 50 cases treated, 66% cases had positive family history and 34% 
had no family history 
Thinai Reference 
Out of 50 cases 26%in Kurinji,36% in Mullai,16% in Marutham and  12 % of 
cases in Neithal Nilam. Siddha literature mentioned that Kaba diseases are more common 
in peoples dwelling in Kurinji nilam. 
Seasonal Reference 
 Out of 50 cases, the maximum of 78% cases were affected during Koothirkalam 
and 22% cases were affected during Karkalam.This may be due to altered life style and 
environmental pollution. 
Distribution of three dosham 
 In Vatham all cases had dearrangement in Pranan & Dhevathathan, 25 in 
Viyanan, 36 cases in Samanan & Kirukaran, 11 in Abanan and 7 in Udhanan. 
 In Pitham all cases has dearrangement in Saathagam, 36 cases in Anal Pitham and 
13 cases in Ranjagam. 
 In Kabam, all cases had dearrangement in Avalambagam, 36 cases had 
dearrangement in Kilethegam and 25 cases had derangements in Santhigam. 
Udal Kattugal 
 In seven udal kattugal 100% of cases had dearrangement in saaram.  Affected 
saaram produced depression. 
 13% of cases had dearrangement in senneer. 
Envagai Theruvugal: 
 Naa was affected in 60% cases. 
 Vizhi was affected in26% of cases. 
 Sparisam were affected in all 50  cases. 
 Malam was affected in 22% of cases. 
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Naadi: 
o Vatha Pitha naadi in23 cases. 
o Pitha Vatha naadi in 16 cases. 
o Pitha Kabam naadi in11 cases. 
Neerkuri, Neikuri Reference:  
Regarding moothiram, Neerkuri showed straw coloured urine in all cases, Neikuri 
showed Kabam neer in 44% cases, 36% cases had Pithaneer and 20% cases had 
Vathaneer. 
Clinical features 
 All 50  cases were affected by fever , cough with  expectoration and fatigue,34 
cases were affected by breathlessness , 8 cases  were affected by night cough,constipation 
in 11 and 25 cases were affected by  arthralgia. 
Laboratory Investigation 
 Routine examination of blood test had done for all patients. 37 cases had 
increased lymphocytosis,13 cases had increased neutrophil and increased ESR. After the 
completion of treatment  increased lymphocytosis, neutrophil increased and ESR were 
noted to be normal.   
Assesment of Result 
 According to clinical features, 70% of cases had good relief, 20% of cases had 
moderate relief and 10% of cases had mild relief. 
Statistical Analysis: 
 This study was statistically significant. 
Bio – Chemical Analysis 
 The bio – chemical analysis Surakudara Mathirai  showed the presence of 
Sulphate,Starch,Reducing sugar,Alkaloid and.Terpenoids. Starch and Sugar supply the 
major portion of energy required by  living cells.Sulphate,Alkaloid and Terpenoids acts 
as an active principle in reducing the symptoms of kabasuram. 
Kabasura Kudineer showed the presence of Starch,Iron,Phosphate,Tannic 
acid,Reducing sugar,Alkaloid and Steroids.  Starch and Sugar supply the major portion 
of energy required   by living cells. Tannic acid has anti-bacterial, anti-enzymatic 
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astringent, anti-oxidant and anti-mutagenic properties.Steroids helps in suppressing 
inflammation. Alkaloid acts as an major active principle in reducing the symptoms of 
kabasuram.Iron is essential to transport of oxygen to the tissues. These may be helpful 
for the patients with Kabasuram.   
 
Microbiological Analysis 
The efficacy of the Surakudari Mathirai was found to be moderate antimicrobial 
activity. Details are given in annexure  
The efficacy of the Kabasura Kudineer was found to be moderate antimicrobial 
activity. Details are given in annexure  
 
Pharmacological activities 
 Surakudari Mathirai has significant Antipyretic, Anti-histamine, Anti-
inflammatory activity and moderate Analgesic activity.  Details are given in annexure. 
 Kabasura kudineer has significant antipyretic, anti-inflammatory activity and 
moderate Anti-histamine and Analgesic activity. Details are given in annexure. 
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SUMMARY 
The dissertation work on Kabasuram is chosen by the author. 
 
Various literatures have been collected regarding kabasuram from Siddha texts as 
well as modern text books.  
 
The efficacies of surakudari mathirai and Kabasura kudineer were appreciated 
through the study of this work. 
 
30 Children from OPD & 20 Children from IP ward with Kabasuram were 
selected from different age and sexes from P.G.Kuzhanthai Maruthuvam Department, 
NIS,Chennai-47. 
 
Clinical findings reveal about the disease and its impact in the body. Statistics 
taken with the help of details in the case sheet were dealt in details in observation and 
results which gave clear knowledge about the disease.  
 
No drug reactions like nausea, vomiting diarrhea, abdominal discomfort, skin 
rashes, and drowsiness were reported during the study period. 
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CONCLUSION 
 
 
                 “cw;whdsTk; gpzpasTk; fhyKk; 
                   fw;whd; fUjpr; nray;” 
            -     jpUf;Fws; 
 
 According to great saint Thiruvalluvar in his Thiurkural, stated that before 
designing a treatment, we should look in to the physical condition of patient, condition of 
diseases, duration and onset of disease. 
 
 Treatment was given for the kabasuram on the basis of “Mukkutra theory “. The 
deranged Dhoshas were corrected by the medicine given, “surakudari mathirai and 
Kabasura kudineer”as an internal medicine. Almost all the cases treated with above 
medicine shows remarkable improvement.  
 
 No adverse effects were reported during the course of treatment and the Drug 
evolution was done with the modern parameter.  
 
Clinical results were found to be good in 70% of cases, moderate results in 20% 
of cases and mild results in 10% of cases.  Because of the encouraging results clinically 
the study may be undertaken in a large number of cases and it will give new light in the 
treatment of Kabasuram. 
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ANNEXURE-1 
PREPARATION AND PROPERTIES OF THE                                                          
TRIAL DRUG 
 
     SURAKUDARI MATHIRAI 
 
            RuFlhhp khj;jpiu 
Njitahd ruf;Ffs;: 
 fow;rp gUg;G  - 100 fpuhk; 
 ngUq;fhak;    - 25 fpuhk; 
 kpsF   - 50 fpuhk; 
 Njd;   - Njitahd msT 
nra;ghfk;: 
 ,it %d;wAk;  vLj;J Rj;jk; nra;J fy;tj;jpy; Njd; tpl;L miuj;J 
250kp.fp mstha; khj;jpiufs; nra;J epoypy; cyHj;jp itj;Jf; nfhs;s 
Ntz;Lk;. 
msT: 
½-1 khj;jpiu B.D. taJf;Fk; td;ikf;Fk; jf;fthW. 
Mjhuk; : 
Nfhrhap mDNghf itj;jpa gpuk;k ,ufrpak; (ghfk; 2) gf;fk; 241. 
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KABASURA  KUDINEER: 
    fgRu FbePH                  
Njitahd ruf;Ffs;: 
1.  fz;lq;fj;jphp NtH - 10 fpuhk; 
2.  J}JNtis NtH   - 10 fpuhk; 
3.  Rz;il NtH  - 10 fpuhk; 
4.  nrk;Ks;sp NtH  - 10 fpuhk; 
5.  Rf;F       - 10 fpuhk; 
 
nra;ghfk;: 
 NkNy nrhy;yg;gl;l Ie;J ruf;FfisAk; tiff;F 10 fpuhk; vLj;J 
xd;W$l;b FbePH nra;J jf;f mstpy; fhiy> khiy ,UNtisAk; nfhLj;Jtu 
fgRuq;fs; jPUk;. 
msT: 
 15- 30 kpyp. ; taJf;Fk; td;ikf;Fk; jf;fthW 
Mjhuk;:  
     Nfhrhap mDNghf itj;jpa gpuk;k ,ufrpak; (ghfk; 2) gf;fk; 243 
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ANNEXURE-2 
 
         REVIEW OF LITERATURES OF TRIAL DRUGS 
ngUq;fhak; 
Botanical Name  : Ferula asafoetida 
Family   : Umbelliferae 
NtWngaH   : mj;jpahfpufk;>,q;F>,uzk;> 
,uhklk;>fe;jp>ty;yPfk;>fhak;> 
re;Jehrk;>G+jehrk;. 
gad;gLk; cWg;G  : gprpd; 
Rit    - ifg;G> fufug;G 
jd;ik   - ntg;gk; 
gphpT    - fhHg;G 
nra;if   - Nfhioafw;wp 
      GOf;nfhy;yp 
       mfl;Ltha;tfw;wp 
       ntg;gKz;lhf;fp 
       ,rptfw;wp 
       kykpsf;fp 
       rpWePh;ngUf;fp 
nghJFzk;: 
   je;jNt je;j %yj;njOk;gpzp 
    rUtfhsk; tpUr;rpfq;fPlk;kh 
   ke;jk;thjk; cjhth;j;jk; my;Fy;Neha; 
khh;gzq;fl;l Fd;kk;kNfhjuk; 
   ce;Jnfh;g;gj;jpd; ypj;jpuQ;#iyr;#h; 
    cjpug;Gr;rp rpNyj;JWk;typ 
   te;jnka;f;fLg; NghBitKw;Wk;Nk 
    khAehWew; fhaq;fpilf;fpNd. 
- NjiuaH Fzthflk; 
,jdhy;>gy;yb Neha;fs;> ghk;G eQ;Rfs>Njs; 
eQ;R>ke;jk;>Vg;gk;>thjk;>      
#jfthA> Fd;kk;>kNfhjuk; #jf#iy>Iaj;jhy; gpwe;j typfs; Nghk;  
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Chemical constituents: 
Asarenitannols A & B, Ferulic Acid, Umbelliferone,10-17% volatile oils. 
                      kpsF 
Botanical Name  : Piper nigrum 
Family   : Piperaceae 
NtWngaH   :: fypid> fwp> fhak;> Nfhsfk;>  
jpuq;fy;> kphpay; >rUkge;jk;> 
ts;sprk;> khrk;> FWkpsF> 
kiyahsp 
English Name   : Black Pepper 
gad;gLk; cWg;G  : tpij> nfhb 
Rit    - ifg;G> fhHg;G 
jd;ik   - ntg;gk; 
gphpT    - fhHg;G 
nra;if       -     fhwYz;lhf;fp 
       mfl;Ltha;tfw;wp 
       Kiwntg;gfw;wp> 
       jbg;Gz;lhf;fp 
       ntg;gKz;lhf;fp 
       tPf;fq;fiur;rp 
       thjklf;fp 
       er;rhp    
nghJFzk;: 
 rPjRuk; ghz;L rpNyj;kq; fpuhzpFd;kk; 
 thjk; mUrpgpj;jk; kh%yk; - XJrd;dp 
 ahrkg]; khuk; mld;Nkfk; fhrkpit 
 ehrq; fwpkpsfpdhy; 
    - mfj;jpaH Fzthflk;. 
 ,jdhy;> FspHRuk;> ghz;L> Nfhio> fopr;ry;>  Fd;kk;> thA> Ritapd;ik> 
ntwp> %yk;> rd;dpahrk;> mg];khuk;> gpuNkfk;> ,Uky;> gf;fthjk;> Fa;aNuhfk;> 
Nrhzpjthjk;> fsNeha;> nrtptyp> ,uj;jFd;kk;> nrhpahik> fhkhiy ,it 
NghFk;. 
Chemical constituents: 
  Piperine, piperidine, chavicin, Starch, Lignin, gum 
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fow;rp 
Botanical Name  - Caesalpinia crista 
Family   - Caeselpiniaceae 
NtWngaH       -      t[;[pugPrk;>fow;fha;>fha;> 
                           fr;rf;fha;>FNguhl;rp  
English Name   - Bonduc nut 
gad;gLk; cWg;G  - ,iy>NtH>gl;il>nfhl;il. 
Rit    - ifg;G 
jd;ik   - ntg;gk; 
gphpT    - fhHg;G 
nra;if   - GOf;nfhy;yp 
       ,rptfw;wp> 
            ntg;gfw;wp> 
       Kiwntg;gfw;wp 
   cukhf;fp   
nghJFzk; 
   tpiuthjk; #iyaWk; ntl;ilad NyFk; 
   epiuNrHe;j Fd;kk;; epiyah-JiuNrH 
   mow;rp tpyFk; mUe;jpw; frg;ghq  
   fow;rpapiy nad;Wiuf;Fq; fhy; 
- mfj;jpaH Fzthflk; 
,jdhy; mz;lthA> #iyf;fl;L> nts;is>gytpj Fd;kk;>cs;soiy  
Mfpait xopAk;. 
Chemical constituents: 
 Tetracosapentate, & Hexaclecadienoic acid. 
  
 
Njd; - HONEY 
 rpj;j kUj;Jtj;jpy; Njd; xU Kf;fpa mDghdkhfTk;> mtpo;jkhfTk; 
gad;gLfpwJ. 
 “mDghdj;jhNy atpo;jk; gypf;Fk; 
 ,dpjhd Rf;F fd;dy; ,Q;rp - gpDKjfhy; 
 NfhNkak; ghy; Kiyg;ghy; Nfhnea; Njd; ntw;wpiy ePH 
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 Mkpij ahuha;e;J nra;ayhk;.” 
- NjiuaH ntz;gh. 
 Njdpy; clYf;Fj; Njitahd ,dpg;Gr;rj;J> cNyhf rj;Jf;fs;> 
itl;lkpd; Nghd;w vy;yh rj;JfSk; mlq;fpAs;sJ.Njd; 12 ehopifapy; 
[PuzkhfptpLtjhy;> ,J clypy; tpiutpy; NrHe;J gyj;ijf; nfhLf;fpwJ. 
nra;if: 
  cs;soyhw;wp 
  mOfyfw;wp 
  JtHg;gp 
  Ngh\zfhhp 
  grpj;jPj;J}z;b 
  Nfhioafw;wp 
  J}f;fKz;lhf;fp 
tiffs; 
  Njdpy; 5 tif cz;L.  mit 
1. kiyj;Njd; 
2. nfhk;Gj;Njd; 
3. kug;nghe;JNjd; 
4. Gw;Wj;Njd; 
5. kidj;Njd; 
,jpy; ngUk;ghYk; kiyj;Njd; kUe;jhf gad;gLfpwJ. 
nghJf;Fzk; - kiyj;Njd ; 
  “IakpUk yPistpf;f yf;fpg;Gz; ntg;Gly;Neha; 
  iga nghopAk; grpAKWk; - itafj;jp 
  nyz;Zkpir ahkUe;jpw; Nfw;w tDghd 
  ez;Zkiyj; Njndhd;wp dhy;” 
 kiyj;Njdpdhy; fgfhrk;> Rthrk;> tpf;fy;> fz;tpuzk;> Ruk;> Njff; fLg;G 
Kjypa gpzpfs; ePq;Fk;.  grpAk; njhdpAk; cz;lhFk; ,J kUe;JfSf;F 
ew;Wiz kUe;jhFk;. 
 Foe;ijfspd; ,UkYf;Fj; Njd; 2 mTd;]; tpshtpd fhb my;yJ 
vYkpr;rk;gourk; rkd;$l;b Fiwe;j mstpy; nfhLj;Jtuj; jzpAk;. 
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MEDICINAL USES OF HONEY: 
1. As an antimicrobial agent honey may have the potential for treating a variety of 
ailments.i.e. Particular type of honey may be useful in treating MRSA infections. 
2. Antibacterial properties of honey used to alleviate the effects of a sore throat, by 
mixing with lemon juice and consumed. The mixture coats the throat alleviating 
discomfort, and the antibacterial, antiseptic properties are good for the throat as 
well. 
3. Medical hydrogen peroxide, commonly 3% by volume, it is present in a 
concentration of only 1 mmol/L in honey. When used topically (as, for example, a 
wound dressing), hydrogen peroxide is produced by dilution with body fluids. As 
a result, hydrogen peroxide is released slowly and acts as an antiseptic 
4. The pH of honey is commonly between 3.2 and 4.5. This relatively acidic pH 
level prevents the growth of many bacteria 
5. Honey has also been used as a treatment for sore throats and coughs for centuries 
6. Honey (especially when combined with lemon) is often taken orally by 
pharyngitis and laryngitis sufferers, in order to soothe them 
7. For sore throats honey not only soothes throats but can also kill certain bacteria 
that cause the infection.  
     fz;lq;fj;jphp 
Botanical Name  : Solanum xanthocarpum 
Family   : Solanacae 
English Name  : Bitter sweet woody night shade 
gad;gLk; cWg;G  : r%yk; 
Rit    : fhHg;G 
jd;ik   : ntg;gk; 
gphpT    : fhHg;G 
nra;if:       :     mfl;Ltha;tfw;wp 
         Nfhioafw;wp 
       rpWePh;ngUf;fp 
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nghJf;Fzk;:: 
   fhr Rthrq; fjpj;jra ke;jkdy; 
   tPRRuQ; rd;dp tpisNjhlk;-MRWqdhy; 
   ,j;jiuA zpw;fh vhpfhuQ; NrHf;fz;lq; 
   Dj;jphpAz; lhkhfpw; fhz;. 
                                    -mfj;jpaH Fzthflk;. 
  ,jdhy;>fhrk;>Rthrk;>rak;>mf;fpdp ke;jk;>jPr;Ruk;>rd;dp>thjk;>VO 
tifj; Njhlq;fs;>thj Neha; Nghk;. 
Chemical constituents: 
 Alkaloids: Solamargine, Solasonine, Solasonine, Tomatidenol, 
 
J}JNtis: 
Botanical Name  : Solanum trilobatum 
Family   : Solanaceae 
NtWngaH   : J}Jtis>msh;f;fk;>rpq;fty;yp; 
Rit    : fhHg;G>rpWifg;G 
jd;ik   : ntg;gk ; 
gphpT    : fhHg;G  
nra;if:       :     cukhf;fp 
         Nfhioafw;wp 
           ntg;gKz;lhf;fp 
nghJFzk;: 
  J}JNtis iaAzj; njhf;fpdpw; nwhf;fpa 
  Ntijah Nehnayh nka;iatpl; lfYNk. 
      -Njud; fupry; 
 J}Jntisia>fw;g;KiwahfNtDk;>fwpahNtDk; cl;nfhz;Ltu> clypy; 
Iaj;jhy; Vw;g;gl;l Neha;fs; jPUk;. 
Chemical constituents: 
 Steroidal alkaloid Solasodine and Tamatidenol.  
 
Rz;il 
          Botanical Name  : Solanum torvum 
Family   - Solanace  
NtWngaH   - kiyRz;il>fLfp.; 
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English Name  - Un named night shade 
gad;gLk; cWg;G  - fha;>tw;wy;>Nth;. 
Rit    - ifg;G 
jd;ik   - ntg;gk; 
gphpT    - fhHg;G 
          nra;if   - El;GOnfhy;yp 
       grpj;jpJ}z;b 
     Nfhioafw;wp 
nghJFzk;: 
  neQ;rpd; fgk;Nghk; epiwfpUkp NehAk;Nghk; 
  tpQ;Rth jj;jpd; tpisTk;Nghk;-tQ;rpaNu 
  thiaf; frg;gpf;Fdk; khkiyapy; cs;sRz;ilf; 
  fhiar; Ritg;gtHf;Ff; fhz;. 
 neQ;rpw;wq;fpa Iak;> Ez;Gothy; cz;lhd Nehafs; tspg;ngUf;F ,it 
Nghk;.  
Chemical constituents: 
 Solosonine, Jurubine, Jurubidine. 
nrk;Ks;sp  
Botanical Name  - Barleria prionitis 
Family   - Acanthaceae 
English Name  - Sahacharah plant 
gad;gLk; cWg;G  - r%yk;. 
Rit    - ifg;G>  
jd;ik   - ntg;gk; 
gphpT    - fhHg;G 
nra;if   - fpUkpehrpdp 
     rpWePh;ngUf;fp 
     Nfhioafw;wp 
     tpah;itngUf;fp 
Uses: 
 Sahacharah is widely used in neurological paqaraplegia and sciatica. 
 When applied over it reduces swelling and glandular swelling. 
Chemical constituents: 
 Barlerin, Acetyl Barlerin, Shanzhiside methylester,Gentoside. 
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Rf;F 
   Botanical Name   : Zingiber officinale Rosc 
  Family    : Zingiberaceae 
  English    : Dried Ginger 
  NtWngaH    : mUf;fd;, mjfk; , 
MHj;ufk; , cgFy;yk; , cyHe;j ,Q;rp, fLgj;jpuk; , Rf;F, Rz;b, 
nrhz;b, nrsgd;dk,; nrstHzk,; etRW, ehfuk; , knes\jk; , 
tpr;tNg\[k; , tpl%ba mkpHjk;, NtHf;nfhk;G 
gad;gLk; cWg;G           :  fpoq;F (cyHe;jJ) 
Rit                      : fhHg;G 
jd;ik                     : ntg;gk;   
gphpT                       :  fhHg;G 
           nra;if                     : ntg;gKz;lhf;fp 
                                     grpj;jPj;J}z;b 
                                 mfl;Ltha;tfw;wp 
nghJf;Fzk;: 
 “R+iyke;jk; neQ;nrhpg;G NjhlNkg; gk;koiy 
 %yk; ,iug;gpUky; %f;FePH - thyfg 
 Njhlkjp rhue; njhlHthj Fd;kePHj; 
 Njhlk;M kk;Nghf;FQ; Rf;F” 
- mfj;jpaH Fzthflk; 
Rf;fpdhy; nrhpahik, khHnghpr;ry;, GspNag;gk;, ntg;gk;, fPo;tha;Neha;, 
,iug;G, ,Uky;, fopr;ry;, ePNuw;wk;, Fd;kk,; tapw;Wg;gprk;, fhJFj;jy;, 
KfNeha;, jiyNeha;, R+iytyp, ghz;L, tapw;Wf;Fj;jy; IaRuk;Nghk;. 
“thjg; gpzptap W}jw; nrtptha; 
 typjiy typFiy typapU tpopePh 
rPjj; njhLthp Ngjpg; gyNuh 
 rpfkyp Kfkf Kfkpb fgkhH. 
rPjr; Ruk;tphp Ngjr; RuNeha; 
 njwpgLnkdnkhop FtHGtp jdpNy 
<Jf; FjTkp jPJf; Fjth 
 njDk;tpjp apiyet RWFz KdNt.” 
     - Njud; Fzthflk; 
thjg;gpzp, jiytyp, Fiytyp, RuNeha; Nghk;. 
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Rf;Ff; fw;gk;: 
 Rf;fpidg; nghbnra;J R+uzkhf;fp 
 apf;fpuj; jpYz;bl tapw; nwhpT Nghq; 
 FbePh nra;jijf; Fbepj ed;ikahk; 
- Njud; ntz;gh 
Rf;Fj;J}isf; fUk;G ,urj;jpy; NrHj;Jf; fhiyapYl;nfhs;s tapw;nwhpr;ry; 
ePq;Fk;.  Rf;Ff;FbePh clYf;F vg;NghJk; ed;ikiar; nra;Ak;. 
 “Rf;fpw;F kpQ;rpa kUj;Jtkpy;iy” 
 vd;gJ fpuhkj;Jg; gonkhop 
Chemical constituents: 
Volatile oils (bisabolene, cineol, phellandrene, citral, borneol, citronellol, 
geranial, linalool, limonene, zingiberol, zingiberene, camphene), Oleoresin (gingerol, 
shogaol), Phenol (gingeol, zingerone), Proteolytic enzyme (zingibain), Vitamin B6, 
Vitamin C, Calcium, Magnesium, Phosphorus, Potassium, Linoleic acid.  
The pungency of ginger is due to GINGEROL which is the alcohol group of the 
oleoresin (when resins are associated with volatile oils, they are called OLEORESINS). 
Ginger owes its aroma to about 1 to 3% of volatile oils, which are bisabolene, 
zingiberene and zing 
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SURAKUDARI MATHIRAI       KABASURA KUDINEER  
 
 
         
 
 
        DRUGS    FOR     SURAKUDARI     MATHIRAI 
   
          
           CESALPENIA CRISTA                                               PIPER NIGRUM 
 
                                       
 
        FERULA ASAFOETIDA                                                    HONEY 
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                   DRUGS   FOR   KABASURA   KUDINEER 
 
 
 
 
 
      SOLANUM XANTHOCARPUM                                      SOLANUM TORVUM 
 
                                        
 
 
                                                       ZINGIBER OFFICINALE 
 
           
 
 
          SOLANUM TRILOBATUM                                        BARLERIA PRIONITIS 
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               ANNEXURE-3 
 
ANALYAIS 
 
 
 
 
ANALYSIS OF SURAKUDARI MATHIRAI 
 
 
 
 
 
TABLE 1: BIOCHEMICAL ANALYSIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Parameters Results 
1 Calcium Absent 
2 Sulphate Present 
3 Chloride Absent 
4 Carbonate Absent 
5 Starch Present 
6 Iron ferrous Absent 
7 Phosphate Absent 
8 Albumin Absent 
9 Tannic acid Absent 
10 Unsaturation Absent 
11 Reducing sugar Present 
12 Amino acid Absent 
13 Alkaloid Present  
14 Steroid Absent 
15 Terpenoids Present 
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ACUTE TOXICITY STUDY 
 TABLE 2: TOXICITY EVALUATION OF SURAKUDARI MATHIRAI 
 
Treatment                      Dose                       Survived animals/ 
                                                       (mg/kg)                             total (%) 
Control (vehicle honey 1ml)  -   5/5 (100) 
Surakudari mathirai   500   5/5 (100) 
 
                       1000   5/5 (100) 
                        2000   5/5 (100) 
Inference: The drug (Surakudari mathirai) showed no toxic effect upto an oral dose of 
2g/kg b.wt. 
ANALGESIC ACTIVITY 
TABLE 3. EFFECT OF SURAKUDARI MATHIRAI ON ACETIC ACID 
INDUCED WRITHES IN MICE 
Treatment  Dose 
(mg/100g) 
No.of 
writhings 
Inhibition(%) 
Control Honey 
(1.0ml) 
46.7 ± 4.1 --- 
100 34.1 ± 2.9 26.9 Surakudari 
mathirai 
200 21.3 ± 2.8** 54.3 
Standard – 
Paracetamol 
20 mg 14.0 ± 1.8*** 70.0 
 
Values are expressed as mean ± SEM of 5 rats. ***P<0.001; **P<0.01 Vs control group. 
 
 
Inference: The drug (Surakudari mathirai) showed moderate analgesic effect. 
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TABLE 4: ANTIPYRETIC EFFECT OF SURAKUDARI MATHIRAI 
 
Initial temp. in 0C S.No. Group Dose 
/100 gm 
0hr 1 ½ hr 3 hrs 
1. Control – 
Honey 
1 ml 39.5 40.0 40.0 
2. Standard – 
Ibuprofen  
20 mg 39.0 38.0 36.0 
100 mg 39.5 38.6 38.0 3. Surakudari 
mathirai 
200mg 39.0 37.6 35.8 
 
Inference: The drug (Surakudari mathirai) showed significant antipyretic effect. 
 
TABLE 5: ANTIMICROBIAL ACTIVITY OF SURAKUDARI MATHIRAI (SM) 
Diameter of  inhibition zone in mm 
Drug  (SM) concentration 
(mg/disc) 
  
Name of Organisms Control 
0.5 1.0 
Standard 
Chloromp
henicol 
(10µg/ml/d
isc) 
Klebseilla aerogenes - - - 18 
Staphylococcus aureus - 6 10 22 
Escherichia coli - 6 12 19 
Pseudomonas 
aeruginosa 
- 4 9 21 
 
Interference: The drug (Surakudari mathirai) showed antimicrobial activity. 
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TABLE 6: EFFECT OF SURAKUDARI MATHIRAI ON CARRAGEENAN 
INDUCED HIND PAW EDEMA IN RATS 
 
Paw volume (ml) Drug Dose 
(mg/kg) Before 
Carrageenan 
Carrageenan  
after 3hr 
Inhibition 
(%) 
Control Honey 2.16 ± 0.02 5.09 ± 0.33 - 
100 2.17 ± 0.02 3.27 ± 0.28* 62.4 Surakudari 
Mathirai 
200 2.14 ± 0.02 2.88 ± 0.21** 74.7 
Indomethacin 10 2.13 ± 0.02 2.26 ± 0.11** 95.5 
Values are expressed as mean ± SEM of 5 rats. *P<0.05; **P<0.01 Vs control group. 
 
 
Inference: The drug (Surakudari mathirai) showed anti-inflammatory effect. 
 
Table 7: ANTIHISTAMINIC ACTIVITY OF SURAKUDARI MATHIRAI 
Group Dose 
(mg/kg) 
Preconvulsion %Inhibition Plasma 
histamine 
(pmoles/ml) 
Control (honey)  1ml 156.4 ± 1.1 - 9.5 ± 0.9 
Surakudari 
Mathirai 
200 222.5 ± 2.1** 70.2 6.9 ± 0.6* 
Cetrizine - 
standard 
10 212.9 ± 2.2** 73.4 3.5 ± 0.3** 
Values are expressed as mean ± SEM of 5 rats. *P<0.05, **P<0.01 Vs control group. 
 
Inference: The drug (Surakudari mathirai) showed significant anti-histamine effect. 
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KABASURA KUDINEER 
TABLE 1: BIOCHEMICAL ANALYSIS 
S.No Parameters Results 
1 Calcium Absent 
2 Sulphate Absent 
3 Chloride Absent 
4 Carbonate Absent 
5 Starch Present 
6 Iron ferrous Present 
7 Phosphate Present 
8 Albumin Absent 
9 Tannic acid Present 
10 Unsaturation Present 
11 Reducing sugar Present 
12 Amino acid Absent 
13 Alkaloid Present 
14 Steroid Present 
15 Terpenoids Absent 
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ACUTE TOXICITY STUDY 
TABLE 2:  TOXICITY EVALUATION OF KABASURA KUDINEER 
 
Treatment                      Dose                       Survived animals/ 
           (mg/kg)                           total (%) 
Control (distilled water)  1.0ml   6/6 (100) 
Kabasura Kudineer   500   6/6 (100) 
 
                       1000   6/6 (100) 
                        2000   6/6 (100) 
Inference: The drug (Kabasura Kudineer) showed no toxic effect upto an oral dose of 
2g/kg b.wt 
 
 
 
TABLE 3. ANALGESIC ACTIVITIES OF KABASURA KUDINEER (HOT 
PLATE TEST) 
Treatment  Dose(mg/100g) Time (min) Reaction time (sec) 
0 11 
30 10 
Control 
(distilled 
water) 
1.0ml 
60 9 
0 10 
30 12 
100 
60 13 
0 10 
30 13 
Kabasura 
Kudineer 
200 
60 15 
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0 10 
30 16 
Standard – 
Paracetamol 
20  
60 18 
Inference: The drug (Kabasura Kudineer) showed moderate analgesic effect. 
TABLE 4: ANTIPYRETIC EFFECT OF KABASURA KUDINEER 
Initial temp. in 0C S. 
No. 
Group Dose/ 100 gm 
0hr 1 ½ hr 3 hr 
1. Control (distilled water) 1 ml 38.0 39.0 41.0 
2. Standard – Ibuprofen 10 mg 37.0 36.0 36.0 
100 mg 38.0 38.0 37.0 3. Kabasura Kudineer 
200mg 37.0 36.0 35.0 
 
Inference: The drug (Kabasura Kudineer) showed significant antipyretic effect. 
 
TABLE 5: ANTIMICROBIAL ACTIVITY OF KABASURA KUDINEER (KK) 
Diameter of  inhibition zone in mm 
Drug  (KK) 
concentration (mg/disc 
  
Name of 
Organisms 
Control 
0.5 1.0 
Standard 
Chloromphenicol 
(10µg/ml/disc) 
Klebseilla 
aerogenes 
- - - 18 
Staphylococcus 
aureus 
- 8 15 22 
Escherichia coli - 6 14 19 
Pseudomonas 
aeruginosa 
- 4 11 21 
 
Inference: The drug (Kabasura Kudineer) showed antimicrobial activity. 
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TABLE 6: EFFECT OF KABASURA KUDINEER ON CARRAGEENAN 
INDUCED HIND PAW EDEMA IN RATS 
 
Paw volume (ml) Drug Dose 
(ml/kg) Before 
Carrageenan 
Carrageenan 
 after 3hr 
Inhibition 
(%) 
Control (water) 1.0 2.24 ± 0.17 4.86 ± 0.42 - 
1.0 2.15 ± 0.13 3.12 ± 0.38 62.9 Kabasura 
Kudineer 
2.0 2.12 ± 0.11 2.44 ± 0.31* 87.7 
Indomethacin 10 2.09 ± 0.17 2.24 ± 0.29* 94.2 
Values are expressed as mean ± SEM of 5 rats. *P<0.05 and **P<0.01 Vs control group. 
Inference: The drug (Kabasura Kudineer) showed significant anti-inflammatory effect. 
 
 
 
 
 
Table 7: ANTIHISTAMINIC ACTIVITY OF KABASURA KUDINEER 
Group Dose (mg/kg) Preconvulsion %Inhibition Plasma 
histamine 
(pmoles/ml) 
Control 
(Distilled 
water) 
 1ml 156.4 ± 1.1 - 9.7 ± 0.7 
Kabasura 
kudineer 
200 236.7 ± 1.9** 66.07 5.8 ± 0.4* 
Cetrizine - 
standard 
10 262.8 ± 2.2** 59.5 3.1 ± 0.2** 
Values are expressed as mean ± SEM of 5 rats. *P<0.05, **P<0.01 Vs control group. 
 
Inference: The drug (Kabasura Kudineer) showed moderate anti-histamine effect. 
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ANNEXURE-4 
 
STASTICAL ANALYSIS 
 
Table : 1 Results of Statistical Analysis Objective Parameters Observed Before  & After 
Treatment of 50 Patients of Kabasuram. 
 
 
 
 
Mean   
Parameter Before 
Treatment 
After 
Treatment 
Difference 
 
Paired t 
test 
 
Probability 
(p) Value 
Statistical 
Significance 
of the 
Difference 
1 Fever(ºF) 100.2 98.4 1.8  t =7.9779 P<0.0001 Significant 
2 ESR-
1/2hr(mm) 
17.78 8.88 8.9  t =7.9891 P<0.0001 Significant 
3 ESR-
1hr(mm) 
35.3 17.72 17.58 t  =8.4822 P<0.0001 Significant 
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ANNEXURE-5 
 
NATIONAL INSTITUTE OF SIDDHA, CHENNAI-47 
AYODHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
A OPEN CLINICAL TRIAL OF SIDDHA DRUGS SURAKUDARI 
MATHIRAI AND KABASURA KUDINEER IN THE TREATMENT OF 
KABASURAM (ACUTE BRONCHITIS) 
 
CONSENT FORM 
 
Certificate by Investigator 
 
          I certify that I have disclosed all details about the study in the terms readily 
understood by the patient. 
 
 
Date: ______________                                        Signature: ______________ 
 
                                                                               Name: _________________ 
Consent of Informant 
 
          I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my Son/Daughter body 
functions. 
 
          I am aware of my right to opt out of the trial to my Son/Daughter at any time 
during the course of the trial without having to give the reasons for doing so. 
 
         I, exercising my free power of choice, hereby give my consent to be included  my 
Son/Daughter as a subject in the clinical trial of Surakudari mathirai and Kabasura 
kudineer in the treatment of Kabasuram 
 
Date:                                                                           Signature  
                                                                                                                   
                                                                                    Name: 
        
                  Relationship: 
 
Date:                                                                          Signature of witness:      
                                                                      
                                                                                   Name:   
 
                                                                                   Relationship:  
 
 87  
NATIONAL INSTITUTE OF SIDDHA, CHENNAI-47 
AYODHIDOSS PANDITHAR HOSPITAL 
DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
A OPEN CLINICAL TRIAL OF SIDDHA DRUGS SURAKUDARI MATHIRAI 
AND KABASURA KUDINEER IN THE TREATMENT OF KABASURAM (ACUTE 
BRONCHITIS) 
 
                                      FORM-1  SELECTION PROFORMA 
 
1. OP/IP NO:     
         
2. BED NO:             3. S.NO:      
 
4. Name     : ……………………………………………..  
 
5. Age (Yrs)  : ………..  6.  Gender: M   F  
 
7. Fathers occupation    :  …….………………… …………….. 
 
8. Postal address    : ………………………………………. 
 
………………………………………………………………………………………. 
 
……………………………………. Contact No: ………………………………….. 
 
9. Complaints and Duration  : 
 
 
 
 
 
10. History of Present illness  : 
 
 
 
 
11. Past history   :   Yes    No  
 
12. Family history  :   Yes    No  
 
13. Immunisation history  : Yes    No  
GENERAL EXAMINATION 
14. Body Weight (Kg)                        : 
15.  Height (Cm)                                 : 
16.  Temperature (F)                           : 
17.  Pulse rate / min                            : 
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18.  Heart rate / min                            : 
19.  Respiratory rate / min                  : 
20.  Blood Pressure (mmHg)              : 
                                                                       Yes                   No 
21. Pallor                                             :     
22. Jaundice                                        :    
23. Clubbing                                       :    
24. Cyanosis                                       :    
25. Pedal Oedema                               :    
26. Lymphadenopathy                        :    
27.  Jugular Venous Pressure              :     
 
EXAMINATION OF VITAL ORGANS 
Normal             Abnormal 
28.   CVS    :         _________________ 
29.  Abdomen    :         _______________ 
 
CLINICAL EXAMINATION OF RS 
30.  Inspection   : 
 
31.  Palpation    : 
  
32.  Percussion   : 
  
33.  Auscultation   :  
 
CLINICAL ASSESSMENT 
                                                             Yes             No 
34.  Night Cough   :         
35   Cough with expectoration :         
36.  Wheezing    :         
37.  Breathlessness   :         
38.  Fatigue    :         
39.  Arthralgia    :         
40.  Chest Pain   :          
 
41.  Fever    : 1. Mild  2. Moderate   3.Severe    
 
42.  Sputum                                         : 1. Green   2.Yellow     3.White  
SIDDHA METHODS OF EXAMINATIONS 
 
43.  Nilam                                        :        1. Kurinji   2. Mullai  3. Marutham  
                                                              4. Neithal  5. Paalai   
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44.  Kaala Iyalbu                             :  1. Kaarkaalam  2. Koothirkaalam 3. Munpanikaalam   
                                                            4. Pinpanikaalam  5. Illavenirkaalam   
                                                            6. Muthuvenirkaalam  
45. Udal Iyal                                    :  1. Vatham   2. Pitham    3. Kabam  
                                                               4. Kalappu   5. Mukkutram  
46. Yaakai                                         :  1. Vatham   2. Vatha pitham   3. Vatha kabam  
                                                             4. Pitham     5. Pitha vatham   6. Pitha kabam  
                            7. Kabam   8. Kaba vatham   9. Kaba pitham  
47.  Gunam                                        : 1. Sathuvam   2. Rasatham   3. Thamasam  
PORI PULANGAL    
Normal            Affected 
48.  Mei    :          _________________ 
49.  Vai    :          _________________ 
50.  Kan    :          _________________ 
51.  Mooku    :          _________________ 
52.  Sevi    :          _________________ 
 
KANMENDHIRIUM / KANMAVIDAYAM 
           Normal            Affected 
53.  Kai    :          _________________ 
54.  Kaal    :          _________________ 
55.  Vai    :          _________________ 
56.  Eruvai    :          _________________ 
57.  Karuvai    :          _________________ 
 
UYIR THATHUKKAL 
VATHAM     
Normal            Affected 
58.  Pranan    :          _________________ 
59. Abanan    :          _________________ 
60.  Viyanan    :          _________________ 
61.  Uthanan    :          _________________ 
62.  Samanan    :          _________________ 
63.  Nagan    :          _________________ 
63.  Koorman    :          _________________ 
64.  Kirukaran    :          _________________ 
65.  Devathathan   :          _________________ 
 90  
66.  Dhananjeyan   :          _________________ 
 
PITHAM 
Normal            Affected 
67. Analam    :          _________________ 
68. Ranjagam    :          _________________ 
69. Saathagam    :          _________________ 
70. Alosagam    :          _________________ 
71. Prasagam    :          _________________ 
 
KABAM 
Normal            Affected 
72.  Avalambagam   :          _________________       
73.  Kilethagam   :          _________________ 
74.  Pothagam    :          _________________ 
75.  Tharpagam   :          _________________ 
76.  Santhigam   :          _________________ 
 
UDAL THATHUKKAL 
Normal            Affected 
77.  Saaram    :          _________________       
78.  Senneer    :          _________________       
79.  Oon    :          ________________       
80.  Kozhuppu   :          _________________       
81.  Enbu    :          _________________       
82.  Moolai    :          _________________       
83.  Sukilam /    :          _________________       
 Suronitham 
 
ENVAGAI THERVUGAL 
Normal            Affected 
84.  Naa    :          _________________       
85.  Niram    :          _________________       
86.  Mozhi    :           _________________       
87.  Vizhi    :          _________________       
88.  Sparisam    :          _________________       
 
Malam: 
Normal            Affected 
89.  Niram    :          _________________       
90.  Edai    :          _________________       
91.  Nurai    :           _________________       
92.  Elagal    :          _________________       
93.  Erugal               :            ________________________________ 
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MOOTHIRAM: 
Neerkuri 
Normal            Affected 
97.    Niram    :          _________________       
98.    Manam    :          _________________       
99.    Edai    :          _________________       
100.  Nurai    :          _________________       
101.  Enjal    :           ________________       
 
102.  Nei kuri    : 1. Vatham   2. Pitham    3. Kabam   
                   4. Others  
 
103.  Naadi                                          : 1.Vatham  2.Vatha pitham   3.Vatha kabam  
                              4. Pitham   5. Pitha vatham   6. Pitha kabam  
                              7. Kabam   8. Kaba vatham  9. Kaba pitham  
 
LAB INVESTIGATIONS  
 104.  BLOOD 
a) TC (cells/ cu.mm)  :   
b) DC       
N: ___ ___ L: ___ ___ E: ___ ___ M: ___ ___ B: ___ ___ 
c) ESR (mm)    
½ hr: ___ ___ 1 hr: ___ ___ 
  
       d)  Hb(gm%)               : 
 
113.  RBC count (Million cells / cumm): 
 
Peripheral Blood Smear  
       Negative Positive 
114.  Mf     :         
115.  Mp    :         
116.  Widal          :         
 
Urine 
117.  Albumin    :  Nil: ___+: ___+ +: ___+ + +: ____    
118.  Sugar    :  Nil: ___+: ___+ +: ___+ + +: ____   
      Negative Positive 
119. Bile salt    :          _________________       
120. Bile pigment   :          _________________       
121. Urobilinogen   :          _________________       
Deposit 
122.  Pus cells    :          _________________ 
123.  Epithelial cells   :          _________________ 
124.  Red blood cells   :          _________________ 
125.  Casts / Crystal   :          _________________ 
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Motion 
126.  Ova    :          _________________ 
127.  Cyst    :          _________________ 
128.  Occult blood   :          _________________ 
129.  Pus cells    :          _________________ 
 
INCLUSION CRITERIA 
          Yes         No 
130. Aged 3 year to 12 years  :           
131. Willing to attend to OPD  
        on 3rd and 6th day of treatment  :                   
132. Willing to give blood specimen  
        for the investment when required:                   
 
EXCLUSION CRITERIA 
133.  Jaundice    :         
134.  Convulsion   :            
135.  Distended Abdomen  :             
136.  Congenital Heart Diseases  :         
137.  Admitted to trial  :           
132. If Yes,           
i) S.No    :   
 ii) OP / IP 
a. OP   :      
   
b. IP   
            
DRUGS ISSUED  
139.  No. of Tablets   :    
140.  Weight of Kudineer powder (g):  
      DD          MM          YEAR 
 
51. Date    :
  
52. Station    : 
 
 
                                                      
 
        
                                                       Signature of the Docter 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI-47 
       AYODHIDOSS PANDITHAR HOSPITAL 
  DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
A OPEN CLINICAL TRIAL OF SIDDHA DRUGS SURAKUDARI MATHIRAI 
AND KABASURA KUDINEER IN THE TREATMENT OF KABASURAM (ACUTE 
BRONCHITIS) 
FORM I I- ASSESSMENT PROFORMA 
 
1.  OP/IP NO:               
                                          
 
2. S.NO:   
  
 
 
3.  Name:    
 
       DD MM           YEAR 
 
4. Date of Admission   :
  
 
5. Date of Assessment  :
  
 
6. Day of Assessment   :   
 
CLINICAL EXAMINATION OF RS 
 
7.  Inspection    : 
 
8.  Palpation    : 
  
9.  Percussion               : 
  
10.  Auscultation   :  
 
CLINICAL ASSESSMENT 
                                                                       Yes             No 
11.  Night Cough   :         
12   Cough with expectoration :         
13.  Wheezing    :         
14.  Breathlessness   :         
15.  Fatigue    :         
16.  Arthralgia    :         
17.  Chest Pain   :          
 
18.  Fever   :  1. Mild   2. Moderate   3. Severe    
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19.  Sputum   :  1. Green  2. Yellow     3.  White  
 
LAB INVESTIGATIONS (Only on day 6) 
 20. BLOOD 
a) TC (cells/ cu.mm) :  
b)  DC       
N: ___ ___ L: ___ ___ E: ___ ___ M: ___ ___ B: ___ ___ 
c)  ESR (mm)    
½ hr: ___ ___ 1 hr: ___ ___ 
21.URINE 
 
a)   Albumin   :  Nil: ___+: ___+ +: ___+ + +: ____    
b)   Sugar   :  Nil: ___+: ___+ +: ___+ + +: ____   
1. Negative Positive 
c)  Bile salt  :          _________________       
d)  Bile pigment  :          _________________       
e)  Urobilinogen  :          _________________       
f) Deposit 
•  Pus cells  :          _________________ 
•  Epithelial cells    :          _________________ 
•   Red blood cells :          _________________ 
•   Casts / Crystal :          _________________ 
22.Motion 
a)  Ova   :          _________________ 
b)   Cyst   :          _________________ 
c)   Occult blood  :          _________________ 
d)   Pus cells  :          _________________ 
    
TEST IN SIDDHA ASPECTS: 
ENVGAI THERVUGAI 
Normal            Affected 
23.  Naa   :                  _______________    
24.  Niram   :                  _______________    
25.  Mozhi   :                  _______________    
26.  Vizhi   :                  _______________    
27.  Sparisam   :                  _______________    
28.MALAM 
Normal            Affected 
a)   Niram  :                  _______________    
b)   Edai   :                  _______________    
c)   Nurai   :                  _______________    
d)   Elagal  :                  _______________    
e)   Eurgal  : __________________________ 
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29.MOOTHIRAM 
i)   Neerkuri 
Normal            Affected 
a)     Niram   :                  _______________    
b)     Manam   :                  _______________    
c)     Edai   :                  _______________    
d)     Nurai   :                  _______________    
e)     Enjal   :                  _______________    
 
ii).    Nei kuri 
  
  1.  Vatham  2.  Pitham  3.  Kabam  4.  Others  
30.    Naadi: 
  1.  Vatham  2.  Vatha pitham  3. Vatha kabam  
  4.  Pitham  5.  Pitha vatham  6.  Pitha kabam  
  7.  Kabam  8.  Kaba vatham  9.  Kaba pitham  
DRUGS RETURNED 
31.  No of Tablets    :
  
32.  Weight of Kudineer powder (gm) :  
DRUGS ISSUED 
33.  No of Tablets:    : 
34.  Weight of Kudineer powder (gm) :   
35.  RESULT 
 
1. Cured    2.Improved    3. No change    4. Deteriorated  
 
          DD           MM           YEAR 
 
36. Date    :
  
37. Station    : 
 
 
                                                                                                   
          Signature of the Docter 
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INVESTIGATION - OUT PATIENT DEPARTMENT 
Before Treatment After Treatment 
TC  ESR in Hb TC ESR in Hb 
cu 
                                  
DC% mm gm% cu 
                  
DC% mm gm% S.No          Name 
OP 
Number 
Age / 
Sex 
mm P L E M 
½ 
hr 
1hr   mm P L E M 
½ 
hr 
1hr   
1 K.Saravanan AG6236 11/M 6100 62 34 4 - 25 55 8.7 7900 53 45 2 - 20 40 8.7 
2 KVignesh AM4666 8/M 7100 51 45 3 1 6 12 13.1 7100 58 38 4 - 2 4 13.1 
3 K.Karthik AM4667 8/M 7800 53 46 1 - 30 62 9.7 7900 53 45 2 - 20 40 9.7 
4 M.Vignesh AM4677 11/M 6400 55 43 2 - 4 8 9.7 6000 46 47 7 - 2 4 9.7 
5 J.Tabusan AM5448 10/F 5700 50 42 8 - 4 8 8.4 5800 53 42 1 4 4 8 8.4 
6 A.Yogaraj AM5481 11/M 5600 51 40 9 - 22 42 11.3 5700 51 40 9 - 3 6 11.3 
7 K.Barath kumar AM5483 6/M 6700 50 40 8 2 4 8 9.4 6800 52 46 2 - 4 8 9.4 
8 N.Eni arasu AM8064 10/M 8000 45 50 3 - 16 32 12 6100 56 40 4 - 4 8 12 
9 M.Mukesh AN8065 8/M 7400 46 50 4 - 18 36 12.5 7100 58 40 2 - 5 10 12.5 
10 M.SyedaliFathima AO1503 5/F 7900 54 45 2 1 24 48 7.5 8000 65 34 1 - 8 16 7.5 
11 M.Iysha banu AO1529 8/M 7800 60 37 2 1 14 28 11.1 8200 62 44 2 1 2 4 11.1 
12 K.Karthikeyan AO3620 8/F 8200 44 54 2 - 16 32 11 7800 60 37 3 - 6 12 11 
13 R.Nasimma AO3621 9/F 6200 71 27 3 - 16 32 12 7000 57 40 3 - 6 12 12 
14 T.Aswanth AO3622 10/M 8100 40 47 2 1 16 32 10 8800 54 44 2 - 2 4 10 
15 S.Samsath AO3623 12/F 8100 50 49 1 - 32 64 12 8000 67 32 1 - 22 44 12 
 P- Polymorphs L – Lymphocytes E- Eosinophils M- Monocytes 
 
TC – Total count of WBC DC – Differential count of WBC 
 
 
 
16 N.Nargees AO3624 8/F 6200 67 31 2 - 32 64 12 7000 60 39 1 - 10 20 12 
17 R.Razya AO3625 8/F 8200 64 34 2 - 16 32 8 8000 60 38 2 - 4 8 8 
18 K.Sangavi AO4487 7/F 6200 70 27 2 1 30 60 11 6200 72 25 2 1 40 80 11 
19 S.Rajesh kanna AO5342 12/M 8000 41 56 2 1 16 32 7.7 8200 52 46 2 - 20 40 7.7 
20 K.Dhivya AO5350 12/M 8100 51 48 1 - 14 28 14 8100 52 46 2 - 6 8 14 
21 P.Ragavendra AO5666 12/M 6800 45 52 3 - 16 32 10 7000 50 45 3 2 10 20 10 
22 S.Velraj AO5695 11/M 7800 43 51 4 - 18 38 10.6 7800 50 49 1 - 30 60 10.6 
23 B.Ganesh AO6073 9/M 7000 52 47 1 - 6 14 10.2 7000 54 49 1 - 2 4 10.2 
24 R.Surya prakash AO6259 12/M 7200 50 47 3 - 20 40 10.2 7200 55 42 3 - 6 12 10.2 
25 S.Ravendran AO6783 4/M 5900 51 46 3 - 4 8 9.6 6000 50 47 3 - 4 8 9.6 
26 S.Samith AO6786 5/M 7600 60 36 4 - 16 34 7.2 7600 55 42 3 - 8 16 7.2 
27 D.Logesh AO8034 8/M 6200 52 44 3 1 8 16 11 6400 58 40 2 - 4 8 11 
28 B.Sanjay kumar AO8045 9/M 7100 53 44 3 - 4 8 9.7 7000 57 40 3 - 4 6 9.7 
29 S.Gowtham AO8065 11/M 6100 50 46 4 - 6 12 7.2 6000 57 40 3 - 4 8 7.2 
30 V.Ratchna AO8097 10/F 7200 62 37 1 - 40 80 11 7200 54 44 2 - 20 40 11 
P- Polymorphs L – Lymphocytes E- Eosinophils M- Monocytes 
TC – Total count of WBC DC – Differential count of WBC 
 
INVESTIGATION - IN PATIENT DEPARTMENT 
Before Treatment After Treatment 
TC  ESR in Hb TC ESR in Hb 
cu 
                                    
DC% mm gm% cu 
                  DC% 
mm gm% S.No          Name IP Number Age / Sex 
mm P L E M ½ hr 1hr   mm P L E M 
½ 
hr 1hr   
1 K.Ammu 205 4/F 6400 34 43 3 - 24 48 10.8 6800 62 32 5 1 6 14 10.8 
2 S.Hariharan 217 3/M 7600 62 37 1 - 4 8 9.2 6100 60 36 4 - 2 4 9.2 
3 N.Dhushant 248 3/M 6700 43 49 6 2 14 28 8.2 7000 50 45 4 1 4 8 8.2 
4 S. Vasantha priya 256 5/F 7200 63 45 2 - 10 20 9.2 7100 55 44 1 - 2 4 9.2 
5 S.Kaviya 285 10/F 5200 59 37 4 - 30 60 11.2 5200 59 37 4 - 30 60 11.2 
6 S.Priya 286 6/F 6000 55 44 1 - 20 40 10.8 7200 60 38 2 - 6 12 10.8 
7 S.Satish 287 5/M 7200 49 48 3 - 22 44 9 6200 59 38 3 - 6 12 9 
8 N.Gayathri 288 3/F 6500 65 30 5 - 28 54 11 7000 55 42 3 - 8 16 11 
9 N.Vimala 289 6/F 7000 50 49 1 - 10 20 10.2 7000 55 41 3 1 2 4 10.2 
10 KSamuvel 290 5/M 7100 54 49 7 - 25 50 10 7000 58 40 2 - 6 14 10 
11 K.Barath  294 5/M 8100 53 45 2 - 26 42 8.7 8000 50 48 2 - 2 4 8.7 
12 N.Tara Banu 314 12/F 8000 44 54 2 - 20 40 9.1 8000 60 36 3 - 8 16 9.1 
13 M.Tanju nisha 315 12/F 7200 50 48 2 - 30 60 8.9 7200 59 39 2 - 16 32 8.9 
14 J.Elanczhian 316 11/M 7200 53 44 3 - 12 24 11.4 7200 55 43 2 - 6 12 11.4 
15 G.shankar 
narayanan 318 4/M 7300 72 27 1 - 23 46 11 7200 67 32 1 - 16 32 11 
16 B.Gyathri 323 12/F 8200 72 27 1 - 20 40 10 8200 68 30 2 - 6 12 10 
17 S.Kaviya 325 10/F 6200 70 28 2 - 40 60 10 6200 64 34 2 - 20 40 10 
18 P.Jayalakshmi 327 12/F 6200 52 47 1 - 12 32 9.2 6200 49 49 2 - 6 12 9.2 
19 S.Balakrishnan 328 8/M 6000 49 47 4 - 20 40 9.2 6200 49 49 2 - 6 12 9.2 
20 H.Riyas ahemed 329 7/M 5800 47 50 3 - 6 12 8.7 6000 50 47 3 - 4 8 8.7 
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1 K.Saravanan AG6236 11/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 1-2 2-3 nil -ve nor nil nil -ve 
2 KVignesh AM4666 8/Mch -ve -ve no -ve nil nil 2-3 1-2 nil -ve nor nil nil -ve nil nil 1-2 0-1 nil -ve nor nil nil -ve 
3 K.Karthik AM4667 8/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 1-2 2-3 nil -ve nor nil nil -ve 
4 M.Vignesh AM4677 11/Mch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
5 J.Tabusan AM5448 10/Fch -ve -ve no -ve nil nil 2-3 2-3 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
6 A.Yogaraj AM5481 11/Mch -ve -ve no -ve nil nil 2-3 1-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
7 K.Barath kumar AM5483 6/Mch -ve -ve no -ve nil nil 2-3 1-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
8 N.Eni arasu AM8064 10/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 2-3 2-3 nil -ve nor nil nil -ve 
9 M.Mukesh AN8065 8/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 2-3 1-2 nil -ve nor nil nil -ve 
10 M.SyedaliFathi AO1503 5/Fch -ve -ve no -ve nil nil 4-6 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
11 M.Iysha banu AO1529 8/Mch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
12 K.Karthikeyan AO3620 8/Fch -ve -ve no -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve nil nil 1-2 0-1 nil -ve nor nil nil -ve 
13 R.Nasimma AO3621 9/Fch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
14 T.Aswanth AO3622 10/Mch -ve -ve no -ve nil nil 1-4 1-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
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15 S.Samsath AO3623 12/Fch -ve -ve no -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve 
16 N.Nargees AO3624 8/Fch -ve -ve no -ve nil nil 2-4 4-6 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
17 R.Razya AO3625 8/Fch -ve -ve no -ve nil nil 2-6 2-6 nil -ve nor nil nil -ve nil nil 0-1 0-1 nil -ve nor nil nil -ve 
18 K.Sangavi AO4487 7/Fch -ve -ve no -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve 
19 S.Rajesh kanna AO5342 12/Mch -ve -ve no -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
20 K.Dhivya AO5350 12/Mch -ve -ve no -ve nil nil 4-8 4-8 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
21 P.Ragavendra AO5666 12/Mch -ve -ve no -ve nil nil 2-4 2-3 nil -ve nor nil nil -ve nil nil 2-4 4-6 nil -ve nor nil nil -ve 
22 S.Velraj AO5695 11/Mch -ve -ve no -ve nil nil 2-4 2-3 nil -ve nor nil nil -ve nil nil 4-8 4-8 nil -ve nor nil nil -ve 
23 B.Ganesh AO6073 9/Mch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
24 R.Suria prakash AO6259 12/Mch -ve -ve no -ve nil nil 6-8 5-6 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
25 S.Ravendran AO6783 4/Mch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
26 S.Samith AO6786 5/Mch -ve -ve no -ve nil nil 4-6 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
27 D.Logesh AO8034 8/Mch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
28 B.Sanjay kumar AO8045 9/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
29 S.Gowtham AO8065 11/Mch -ve -ve no -ve nil nil 1-2 2-3 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
30 V.Ratchna AO8097 10/Fch -ve -ve no -ve nil nil 2-6 2-6 nil -ve nor nil nil -ve nil nil 1-2 2-1 nil -ve nor nil nil -ve 
 INVESTIGATION - IN PATIENT DEPARTMENT 
 
Before Treatment After Treatment 
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1 K.Ammu 205 4/Fch -ve -ve no -ve nil nil 7-8 7-8 nil -ve nor nil nil -ve nil nil 3-4 3-4 nil -ve nor nil nil -ve 
2 S.Hariharan 217 3/Mch -ve -ve no -ve nil nil 2-3 0-1 nil -ve nor nil nil -ve nil nil 2-3 0-1 nil -ve nor nil nil -ve 
3 N.Dhushant 248 3/Mch -ve -ve no -ve nil nil 1-3 1-2 nil -ve nor nil nil -ve nil nil 1-3 1-2 nil -ve nor nil nil -ve 
4 S. Vasantha priya 256 5/Fch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
5 S.Kaviya 285 10/Fch -ve -ve no -ve nil nil 2-3 4-6 nil -ve nor nil nil -ve nil nil 2-3 4-6 nil -ve nor nil nil -ve 
6 S.Priya 286 6/Fch -ve -ve no -ve nil nil 1-2 0-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
7 S.Satish 287 5/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
8 N.Gayathri 288 3/Fch -ve -ve no -ve nil nil 1-2 2-3 nil -ve nor nil nil -ve nil nil 1-2 2-3 nil -ve nor nil nil -ve 
9 N.Vimala 289 6/Fch -ve -ve no -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
10 KSamuvel 290 5/Mch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
11 K.Barath  294 5/Mch -ve -ve no -ve nil nil 6-8 4-6 nil -ve nor nil nil -ve nil nil 1-2 4-6 nil -ve nor nil nil -ve 
12 N.Tara Banu 314 12/Fch -ve -ve no -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
13 M.Tanju nisha 315 12/Fch -ve -ve no -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
14 J.Elanczhian 316 11/Mch -ve -ve no -ve nil nil 3-5 1-2 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
15 G.shankarnarayan 318 4/Mch -ve -ve no -ve nil nil 3-5 4-6 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
16 B.Gyathri 323 12/Fch -ve -ve no -ve nil nil 4-6 4-6 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
17 S.Kaviya 325 10/Fch -ve -ve no -ve nil nil 4-8 4-8 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
18 P.Jayalakshmi 327 12/Fch -ve -ve no -ve nil nil 2-6 2-6 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
19 S.Balakrishnan 328 8/Mch -ve -ve no -ve nil nil 6-8 6-8 nil -ve nor nil nil -ve nil nil 2-4 2-4 nil -ve nor nil nil -ve 
20 H.Riyas ahemed 329 7/Mch -ve -ve no -ve nil nil 2-3 2-3 nil -ve nor nil nil -ve nil nil 1-2 1-2 nil -ve nor nil nil -ve 
CLINICAL FEATURE IN OUT PATIENT DEPARTMENT 
CLINICAL FEATURE  
  
BEFORE TREATMENT 
  
  
 
AFTER TREATMENT 
  
S NO NAME OP NO AGE/SEX DOA DOD 
Temp 
F 
Cough&Expt Dyspnoea 
Temp 
F 
Cough&Expt Dyspnoea 
1 K.Saravanan AG6236 11/M 25.8.08 30.8.08 101 P A 98.4 A A 
2 KVignesh AM4666 8/M 30.9.08 5.9.08 101 P P 98.4 A A 
3 K.Karthik AM4667 8/M 30.9.08 5.9.08 100.4 P P 98.4 R A 
4 M.Vignesh AM4677 11/M 30.8.08 6.9.08 99.8 P P 99.4 R A 
5 J.Tabusan AM5448 10/F 8.10.08 13.10.08 101 P P 98.4 A A 
6 A.Yogaraj AM5481 11/M 8.10.08 13.10.08 99.4 P A 98.4 A A 
7 K.Barath kumar AM5483 6/M 8.10.08 13.10.08 100 P A 99 P A 
8 N.Eni arasu AM8064 10/M 20.10.08 25.10.08 99 P P 98.4 P A 
9 M.Mukesh AN8065 8/M 20.10.08 25.10.08 101 P P 98.4 A A 
10 M.SyedaliFathima AO1503 5/F 5.11.08 11.11.08 99.8 P P 98.6 R A 
11 M.Iysha banu AO1529 8/M 5.11.08 11.11.08 100 P P 98.6 A A 
12 K.Karthikeyan AO3620 8/F 12.11.08 17.11.08 101 P P 98.6 R A 
13 R.Nasimma AO3621 9/F 12.11.08 17.11.08 99.4 P P 98.6 A A 
14 T.Aswanth AO3622 10/M 12.11.08 17.11.08 100 P A 98.4 A A 
15 S.Samsath AO3623 12/F 12.11.08 17.11.08 101 P P 99.4 P P 
......Contd 
  
 
 
P – Present A – Abscent R - Reduced 
 
 
 
 
 
16 N.Nargees AO3624 8/F 12.11.08 17.11.08 99.8 P P 98.6 R A 
17 R.Razya AO3625 8/F 12.11.08 17.11.08 99.6 P P 98.4 A A 
18 K.Sangavi AO4487 7/F 15.11.08 20.11.08 100 P P 99.6 P P 
19 S.Rajesh kanna AO5342 12/M 17.11.08 22.11.08 99.8 P P 99 R A 
20 K.Dhivya AO5350 12/M 17.11.08 22.11.08 102 P P 98.6 R P 
21 P.Ragavendra AO5666 12/M 18.11.08 23.11.08 99 P P 98 P A 
22 S.Velraj AO5695 11/M 18.11.08 23.11.08 100 P P 100 P P 
23 B.Ganesh AO6073 9/M 19.11.08 24.11.08 99 P P 98.4 P A 
24 R.Surya prakash AO6259 12/M 20.11.08 25.11.08 100 P A 98.6 R A 
25 S.Ravendran AO6783 4/M 22.11.08 27.11.08 99.8 P P 99 R P 
26 S.Samith AO6786 5/M 22.11.08 27.11.08 101 P P 98.4 R A 
27 D.Logesh AO8034 8/M 29.11.08 3.12.08 100 P P 98.6 R A 
28 B.Sanjay kumar AO8045 9/M 29.11.08 3.12.08 101 P P 99.2 R A 
29 S.Gowtham AO8065 11/M 29.11.08 3.12.08 101.6 P A 98.6 R A 
30 V.Ratchna AO8097 10/F 29.11.08 3.12.08 100 P A 98.6 R A 
 CLINICAL FEATURE IN  IN - PATIENT DEPARTMENT 
 
P – Present A – Abscent R - Reduced 
  
  
CLINICAL FEATURE  
 
  
BEFORE TREATMENT 
  
  
AFTER TREATMENT 
  
S 
NO NAME 
IP 
NO AGE/SEX DOA DOD 
Temp F Cough&Expecto Dyspnoea Temp F Cough&Expect Dyspnoea 
1 K.Ammu 205 4/Fch 18.8.08 23.8.08 100 P A 98.6 R A 
2 S.Hariharan 217 3/Mch 5.9.08 10.9.08 100 P A 98.4 R A 
3 N.Dhushant 248 3/Mch 29.9.08 2.10.08 100 P A 98.4 A A 
4 S. Vasantha priya 256 5/Fch 30.9.08 5.9.08 101 P P 98.4 A P 
5 S.Kaviya 285 10/Fch 31.10.08 6.11.08 101 P P 98.6 A P 
6 S.Priya 286 6/Fch 1.11.08 6.11.08 100 P A 98.6 R A 
7 S.Satish 287 5/Mch 1.11.08 6.11.08 101.4 P P 98.6 P P 
8 N.Gayathri 288 3/Fch 1.11.08 6.11.08 100 P A 98.6 R A 
9 N.Vimala 289 6/Fch 1.11.08 6.11.08 101 P P 98.6 P P 
10 KSamuvel 290 5/Mch 2.11.08 7.11.08 100 P P 98.6 R P 
11 K.Barath  294 5/Mch 4.11.08 8.11.08 101 P P 98.4 R P 
12 N.Tara Banu 314 12/Fch 14.11.08 19.11.08 102 P A 98.6 A A 
13 M.Tanju nisha 315 12/Fch 14.11.08 19.11.08 101 P P 98.6 A P 
14 J.Elanczhian 316 11/Mch 17.11.08 22.11.08 99 P P 98.6 R P 
15 G.Sankarnarayanan 318 4/Mch 18.11.08 23.11.08 101 P P 98.6 A P 
16 B.Gyathri 323 12/Fch 19.11.08 24.11.08 100 P A 98.6 R A 
17 S.Kaviya 325 10/Fch 21.11.08 25.11.08 99.8 P P 98.4 R P 
18 P.Jayalakshmi 327 12/Fch 22.11.08 26.11.08 100.2 P A 98.4 R A 
19 S.Balakrishnan 328 8/Mch 22.11.08 26.11.08 100 P A 98.6 R A 
20 H.Riyas ahemed 329 7/Mch 22.11.08 26.11.08 101 P P 99 P P 
